WO1984000003A1
(en)
|
1982-06-14 |
1984-01-05 |
Merrill Edward Wilson |
Process and apparatus for measuring blood viscosity directly and rapidly
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
HUP9902056A3
(en)
|
1996-01-17 |
2002-02-28 |
Novo Nordisk As |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
PL192359B1
(pl)
|
1996-08-30 |
2006-10-31 |
Novo Nordisk As |
Pochodna GLP-1(7-37) lub analogu GLP-1(7-37), środek farmaceutyczny oraz zastosowanie pochodnej GLP-1(7-37) lub analogu GLP-1(7-37)
|
DK0958296T3
(da)
|
1996-12-31 |
2003-08-18 |
Reddys Lab Ltd Dr |
Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
EP1000066A1
(en)
|
1997-07-16 |
2000-05-17 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
CA2819705C
(en)
|
1998-02-02 |
2014-07-08 |
Trustees Of Tufts College |
Method of regulating glucose metabolism, and reagents related thereto
|
AU756965B2
(en)
|
1998-03-12 |
2003-01-30 |
Microbial Chemistry Research Foundation |
Benzofurylpyrone derivatives
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
WO2000034331A2
(en)
|
1998-12-07 |
2000-06-15 |
Societe De Conseils De Recherches Et D'applications Scientifiques Sas |
Analogues of glp-1
|
AUPP891299A0
(en)
|
1999-02-26 |
1999-03-25 |
Fujisawa Pharmaceutical Co., Ltd. |
New 6-membered cyclic compounds
|
EP1173438A1
(en)
|
1999-04-16 |
2002-01-23 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
AU3957600A
(en)
|
1999-04-26 |
2000-11-10 |
Boehringer Ingelheim International Gmbh |
Piperidyl-imidazole derivatives, their preparations and therapeutic uses
|
ATE368037T1
(de)
|
1999-04-28 |
2007-08-15 |
Sanofi Aventis Deutschland |
Di-aryl-säurederivate als ppar rezeptor liganden
|
BR0010126A
(pt)
|
1999-04-28 |
2002-02-26 |
Aventis Pharma Gmbh |
Derivados de ácido tri-arìlico como ligandos receptores de ppar
|
WO2000066585A1
(en)
|
1999-04-30 |
2000-11-09 |
Neurogen Corporation |
9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
|
SI1194425T1
(sl)
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
RU2002107998A
(ru)
|
1999-09-01 |
2003-11-10 |
АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) |
Сульфонилкарбоксамидные производные, способ их получения и их применение в качестве лекарственных средств
|
WO2001019831A1
(en)
|
1999-09-10 |
2001-03-22 |
Novo Nordisk A/S |
MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
|
DE60028791T2
(de)
|
1999-09-10 |
2007-05-24 |
Novo Nordisk A/S |
Modulatoren der protein tyrosin phosphatase (ptpases)
|
EP1214060A2
(en)
|
1999-09-10 |
2002-06-19 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
WO2001021577A2
(en)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Melanin concentrating hormone antagonist
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
DZ3335A1
(fr)
|
2000-03-23 |
2001-09-27 |
Solvay Pharm Bv |
Derives de 4,5-dihydro-1h-pyrazole ayant une activite antagoniste de cb1
|
AU5257401A
(en)
|
2000-04-28 |
2001-11-12 |
Asahi Chemical Ind |
Novel bicyclic compounds
|
JPWO2001085693A1
(ja)
|
2000-05-11 |
2004-01-08 |
萬有製薬株式会社 |
N−アシルテトラヒドロイソキノリン誘導体
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
AU2001264977B2
(en)
|
2000-05-30 |
2005-04-14 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
ATE293101T1
(de)
|
2000-06-16 |
2005-04-15 |
Smithkline Beecham Plc |
Piperidine zur verwendung als orexin rezeptor antagonisten
|
CA2384041A1
(en)
|
2000-07-05 |
2002-01-24 |
Synaptic Pharmaceuticals Corporation |
Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
|
JP2004502423A
(ja)
|
2000-07-05 |
2004-01-29 |
シナプティック・ファーマスーティカル・コーポレーション |
ヒトメラニン濃縮ホルモン受容体(mch1)をコードするdna及びその使用
|
AU2001278508A1
(en)
|
2000-07-31 |
2002-02-13 |
Smithkline Beecham P.L.C. |
Carboxamide compounds and their use as antagonists of a human 11cby receptor
|
DE60120748T2
(de)
|
2000-11-10 |
2007-05-16 |
Eli Lilly And Co., Indianapolis |
3-substituierte oxindolderivate als beta-3-agonisten
|
US20030022891A1
(en)
|
2000-12-01 |
2003-01-30 |
Anandan Palani |
MCH antagonists and their use in the treatment of obesity
|
HUP0401073A2
(hu)
|
2000-12-21 |
2004-09-28 |
Aventis Pharma Deutschland Gmbh. |
Difenilazetidinon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
|
KR100833089B1
(ko)
|
2000-12-21 |
2008-05-29 |
사노피-아벤티스 도이칠란트 게엠베하 |
신규한 1,2-디페닐아제티딘온 및 당해 화합물을 함유하는 지질 대사 장애를 치료하기 위한 약제학적 조성물
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
ES2265452T3
(es)
|
2000-12-21 |
2007-02-16 |
Vertex Pharmaceuticals Incorporated |
Compuestos de pirazol utiles como inhibidores de la proteina quinasa.
|
PE20020856A1
(es)
|
2001-02-13 |
2002-11-11 |
Aventis Pharma Gmbh |
1,2,3,4-tetrahidronaftil aminas aciladas
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
ATE284872T1
(de)
|
2001-03-22 |
2005-01-15 |
Solvay Pharm Bv |
4,5-dihydro-1h-pyrazolderivate mit cb1- antagonistischer wirkung
|
US6858619B2
(en)
|
2001-05-04 |
2005-02-22 |
Amgen Inc. |
Fused heterocyclic compounds
|
EP1258247A1
(en)
|
2001-05-14 |
2002-11-20 |
Aventis Pharma Deutschland GmbH |
Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
WO2003002776A2
(en)
|
2001-06-28 |
2003-01-09 |
Algat Sherutey Gimur Teufati |
Method of anodizing of magnesium and magnesium alloys and producing conductive layers on an anodized surface
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
CA2462200A1
(en)
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
ES2278077T3
(es)
|
2001-08-31 |
2007-08-01 |
Sanofi-Aventis Deutschland Gmbh |
Derivados de diarilcicloalquilo, procedimiento para su preparacion y su uso como activadores de ppar.
|
WO2007036945A2
(en)
|
2005-09-30 |
2007-04-05 |
Compugen Ltd. |
Hepatocyte growth factor receptor splice variants and methods of using same
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
PL368441A1
(en)
|
2001-09-21 |
2005-03-21 |
Solvay Pharmaceuticals B.V. |
Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
HUP0402113A3
(en)
|
2001-09-21 |
2012-05-29 |
Solvay Pharm Bv |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
CA2461144A1
(en)
|
2001-09-24 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
Preparation and use of pyrrole derivatives for treating obesity
|
GT200200188A
(es)
|
2001-09-24 |
2003-06-25 |
|
Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad
|
HUP0700124A2
(en)
|
2001-10-25 |
2007-06-28 |
Takeda Chemical Industries Ltd |
Quinoline compound
|
BR0214344A
(pt)
|
2001-11-22 |
2004-09-14 |
Biovitrum Ab |
Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
|
IL160630A0
(en)
|
2001-11-22 |
2004-07-25 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
IL161154A0
(en)
|
2001-11-22 |
2004-08-31 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
US7084156B2
(en)
|
2001-11-27 |
2006-08-01 |
Merck & Co., Inc. |
2-Aminoquinoline compounds
|
EP1474139B1
(en)
|
2002-02-01 |
2007-11-21 |
Merck & Co., Inc. |
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
AU2003248354A1
(en)
|
2002-02-27 |
2003-09-09 |
Pfizer Products Inc. |
Acc inhibitors
|
WO2003076442A1
(en)
|
2002-03-05 |
2003-09-18 |
Eli Lilly And Company |
Purine derivatives as kinase inhibitors
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
CA2480856A1
(en)
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Substituted aryl amides
|
AU2003226927A1
(en)
|
2002-04-09 |
2003-10-27 |
7Tm Pharma A/S |
Novel carboxamide compounds for use in mch receptor related disorders
|
WO2003087046A1
(en)
*
|
2002-04-09 |
2003-10-23 |
7Tm Pharma A/S |
Novel aminotetraline compounds for use in mch receptor related disorders
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
IL164249A0
(en)
|
2002-04-11 |
2005-12-18 |
Aventis Pharma Gmbh |
Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
EP1499306A4
(en)
|
2002-04-12 |
2007-03-28 |
Merck & Co Inc |
BICYCLIC AMIDE
|
US7229987B2
(en)
|
2002-05-13 |
2007-06-12 |
Eli Lilly And Company |
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
|
JPWO2003097064A1
(ja)
|
2002-05-17 |
2005-09-15 |
協和醗酵工業株式会社 |
糖尿病治療剤
|
TWI329111B
(en)
|
2002-05-24 |
2010-08-21 |
X Ceptor Therapeutics Inc |
Azepinoindole and pyridoindole derivatives as pharmaceutical agents
|
US7595311B2
(en)
|
2002-05-24 |
2009-09-29 |
Exelixis, Inc. |
Azepinoindole derivatives as pharmaceutical agents
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
EP1375508A1
(en)
|
2002-06-27 |
2004-01-02 |
Aventis Pharma Deutschland GmbH |
N6-substituted adenosine analogues and their use as pharmaceutical agents
|
AU2003248888A1
(en)
|
2002-07-09 |
2004-01-23 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE50312261D1
(de)
|
2002-07-12 |
2010-02-04 |
Sanofi Aventis Deutschland |
Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
BR0312957A
(pt)
|
2002-07-27 |
2005-06-14 |
Astrazeneca Ab |
Composto ou um sal farmaceuticamente aceitável deste, uso do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, em necessidade de tal tratamento
|
AU2003250117B2
(en)
|
2002-07-29 |
2007-05-10 |
F. Hoffmann-La Roche Ag |
Novel benzodioxoles
|
DE60322075D1
(de)
*
|
2002-07-30 |
2008-08-21 |
Merck & Co Inc |
Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
|
EA200500322A1
(ru)
|
2002-08-07 |
2005-08-25 |
Мицубиси Фарма Корпорейшн |
Соединения дигидропиразолопиридина
|
DE10237723A1
(de)
|
2002-08-17 |
2004-07-08 |
Aventis Pharma Deutschland Gmbh |
Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
US20040242572A1
(en)
|
2002-08-24 |
2004-12-02 |
Boehringer Ingelheim International Gmbh |
New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
|
DE10238865A1
(de)
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
CN1678589A
(zh)
|
2002-09-05 |
2005-10-05 |
安万特医药股份有限公司 |
作为药物的新氨基吲唑衍生物与含有它们的药物组合物
|
CA2498272A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
RU2296759C2
(ru)
|
2002-09-12 |
2007-04-10 |
Ф.Хоффманн-Ля Рош Аг |
N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты)
|
WO2004029204A2
(en)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Substituted pyrimidines
|
BR0315166A
(pt)
|
2002-10-11 |
2005-08-16 |
Astrazeneca Ab |
Uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, que necessita de tratamento
|
WO2004037169A2
(en)
|
2002-10-18 |
2004-05-06 |
Merck & Co., Inc. |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
JP2006506366A
(ja)
|
2002-10-18 |
2006-02-23 |
ファイザー・プロダクツ・インク |
カンナビノイド受容体リガンドおよびその使用方法
|
TW200504033A
(en)
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
WO2004037251A1
(en)
|
2002-10-24 |
2004-05-06 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
WO2004041274A1
(en)
|
2002-11-05 |
2004-05-21 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
EP1562574A1
(en)
|
2002-11-07 |
2005-08-17 |
Astrazeneca AB |
2-oxo-ethanesulfonamide derivates
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
KR20050088194A
(ko)
|
2002-12-19 |
2005-09-02 |
머크 앤드 캄파니 인코포레이티드 |
치환된 아미드
|
WO2004058727A1
(en)
|
2002-12-20 |
2004-07-15 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
AU2003297291A1
(en)
|
2003-01-06 |
2004-08-10 |
Eli Lilly And Company |
Substituted arylcyclopropylacetamides as glucokinase activators
|
GEP20084540B
(en)
|
2003-01-14 |
2008-11-25 |
Arena Pharm Inc |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
JP4621198B2
(ja)
|
2003-02-11 |
2011-01-26 |
プロシディオン・リミテッド |
トリ(シクロ)置換アミドグルコキナーゼ活性化化合物
|
RU2005128499A
(ru)
|
2003-02-13 |
2006-01-27 |
Санофи-Авентис Дойчланд Гмбх (De) |
Замещенные у азота производные гексагидропиразино (1,2-а) пиримидин-4, 7-диона, способ их получения и их применение в качестве лекарственного средства
|
DE502004011328D1
(de)
|
2003-02-13 |
2010-08-12 |
Sanofi Aventis Deutschland |
Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
WO2004074288A1
(en)
|
2003-02-19 |
2004-09-02 |
F. Hoffmann-La Roche Ag |
Sulfonamide substituted xanthine derivatives for use as pepck inhibitors
|
WO2004078716A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co. Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
EP1460069A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
EP1460075A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
|
JP2006521359A
(ja)
|
2003-03-26 |
2006-09-21 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としての二環式ピペリジン誘導体
|
WO2004085403A1
(en)
|
2003-03-26 |
2004-10-07 |
Actelion Pharmaceuticals Ltd |
Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
|
DE10314610A1
(de)
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
WO2004092181A1
(en)
|
2003-04-11 |
2004-10-28 |
Smithkline Beecham Corporation |
Heterocyclic mchr1 antagonists
|
WO2004089896A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
|
JP2006522745A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
置換1,2,4−トリアゾールの薬学的使用
|
JP2006522747A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
縮合1,2,4−トリアゾールの薬学的使用
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
JP4531696B2
(ja)
|
2003-04-25 |
2010-08-25 |
パナソニック株式会社 |
マルチメディア情報共有システム
|
US20070173486A1
(en)
|
2003-05-01 |
2007-07-26 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
|
JP2006525298A
(ja)
|
2003-05-01 |
2006-11-09 |
ヴァーナリス リサーチ リミテッド |
アゼチジンカルボキサミド誘導体及びcb1レセプター媒介障害の治療におけるその使用
|
MXPA05011472A
(es)
|
2003-05-01 |
2005-12-12 |
Vernalis Res Ltd |
Uso de derivados de azetidincarboxamida en terapia.
|
BRPI0410289A
(pt)
|
2003-05-07 |
2006-05-16 |
Pfizer Prod Inc |
ligantes do receptor de canabinóides e suas utilizações
|
AU2004238240A1
(en)
|
2003-05-09 |
2004-11-25 |
Merck & Co., Inc. |
Benzimidazoles, compositions containing such compounds and methods of use
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
AU2004240885A1
(en)
|
2003-05-21 |
2004-12-02 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
|
JP2007501861A
(ja)
|
2003-05-23 |
2007-02-01 |
カイロン コーポレイション |
Mc4−rアゴニストとしてのグアニジノ置換キナゾリノン化合物
|
CA2526712A1
(en)
|
2003-05-29 |
2004-12-09 |
Merck & Co., Inc. |
Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
UA83230C2
(ru)
|
2003-06-11 |
2008-06-25 |
Мерк Энд Ко., Инк. |
Замещенные производные 3-алкил- и 3-алкенилазетидинов
|
AU2004251178A1
(en)
|
2003-06-13 |
2005-01-06 |
Janssen Pharmaceutica N.V. |
Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors
|
US20060135523A1
(en)
|
2003-06-18 |
2006-06-22 |
Astrazeneca Ab |
2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
GB0314049D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB0314057D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB0314261D0
(en)
|
2003-06-19 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
WO2005000339A2
(en)
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Melanocortin receptor 4(mc4) agonists and their uses
|
RU2344132C2
(ru)
|
2003-06-20 |
2009-01-20 |
Ф.Хоффманн-Ля Рош Аг |
2-аминобензотиазолы в качестве обратных агонистов рецепторов cb1
|
WO2004113310A1
(en)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
WO2005000974A2
(en)
|
2003-06-27 |
2005-01-06 |
Day-Glo Color Corp. |
Water-based spray marking composition
|
WO2005001921A1
(ja)
|
2003-06-27 |
2005-01-06 |
Nec Corporation |
薄膜トランジスタ、薄膜トランジスタ基板、電子機器及び多結晶半導体薄膜の製造方法
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
CN1832957A
(zh)
|
2003-07-09 |
2006-09-13 |
福布斯梅迪泰克公司 |
包含甾醇和/或甾烷醇及胆固醇生物合成抑制剂的新化合物和组合物 ,以及它们在治疗或预防多种疾病和症状中的用途
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
WO2005007111A2
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
JP2006528180A
(ja)
|
2003-07-22 |
2006-12-14 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としてのピペリジン誘導体
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
CN1832741A
(zh)
|
2003-08-07 |
2006-09-13 |
默克公司 |
作为11-β-羟甾类脱氢酶-1抑制剂的吡唑甲酰胺类
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
WO2005021495A2
(en)
|
2003-08-25 |
2005-03-10 |
Microbia Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
EP1660446A2
(en)
|
2003-08-28 |
2006-05-31 |
Microbia, Inc. |
Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
|
AU2004273865A1
(en)
|
2003-09-18 |
2005-03-31 |
Merck & Co., Inc. |
Substituted sulfonamides
|
TWI336697B
(en)
|
2003-09-19 |
2011-02-01 |
Solvay Pharm Bv |
Thiazole derivatives as cannabinoid receptor modulators
|
TW200526254A
(en)
|
2003-09-19 |
2005-08-16 |
Novo Nordisk As |
Novel GLP-1 derivatives
|
RU2381233C2
(ru)
|
2003-09-30 |
2010-02-10 |
Ново Нордиск А/С |
Агонисты рецептора меланокортина
|
US20060247239A1
(en)
|
2003-10-01 |
2006-11-02 |
Hu Xiufeng E |
Melanin concentrating hormone antagonists
|
WO2005033063A2
(en)
*
|
2003-10-01 |
2005-04-14 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
TW200519105A
(en)
|
2003-10-20 |
2005-06-16 |
Lg Life Science Ltd |
Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
WO2005042516A2
(en)
|
2003-10-22 |
2005-05-12 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
WO2005040109A1
(en)
|
2003-10-22 |
2005-05-06 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
CA2543943A1
(en)
|
2003-10-30 |
2005-05-19 |
Merck & Co., Inc. |
2-azetidinones as anti-hypercholesterolemic agents
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
WO2005042692A2
(en)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
|
PL1682528T3
(pl)
|
2003-11-07 |
2008-01-31 |
Hoffmann La Roche |
Pochodne benzo[b][1,4]dioksepiny
|
WO2005047293A1
(en)
|
2003-11-07 |
2005-05-26 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
CA2545058A1
(en)
|
2003-11-10 |
2005-05-26 |
Microbia, Inc. |
4-biarylyl-1-phenylazetidin-2-ones
|
KR20050045927A
(ko)
|
2003-11-12 |
2005-05-17 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
EP1685102A4
(en)
|
2003-11-12 |
2008-08-20 |
Lg Life Sciences Ltd |
melanocortin
|
KR20060105785A
(ko)
|
2003-11-19 |
2006-10-11 |
카이론 코포레이션 |
감소된 생체축적을 갖는 퀴나졸리논 화합물
|
EP1688138A4
(en)
|
2003-11-26 |
2008-01-16 |
Takeda Pharmaceutical |
AGENT FOR REGULATING THE FUNCTION OF A RECEIVER
|
EP1538159A1
(en)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
EP1694348A4
(en)
|
2003-12-10 |
2009-07-01 |
Merck & Co Inc |
VOLUNTARY INHIBITION OF CONSUMPTION OF ETHANOL USING MELANOCORTIN RECEPTOR 4 RECEPTOR AGONISTS
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
AU2004312001B2
(en)
|
2003-12-19 |
2009-08-27 |
Merck & Co., Inc. |
Cyclic guanidines, compositions containing such compounds and methods of use
|
PT1697370E
(pt)
|
2003-12-19 |
2007-05-31 |
Bristol Myers Squibb Co |
Heterociclos azabicíclicos como moduladores do receptor de canabinóides
|
TW200528455A
(en)
|
2003-12-19 |
2005-09-01 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
PL1697371T3
(pl)
|
2003-12-19 |
2007-09-28 |
Bristol Myers Squibb Co |
Azabicykliczne heterocykle jako modulatory receptora kanabinoidowego
|
EP1557417B1
(en)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
|
WO2005063247A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Aryl sulfonamide compounds and uses related thereto
|
CA2550373C
(en)
|
2003-12-23 |
2012-01-31 |
Merck & Co., Inc. |
Anti-hypercholesterolemic compounds
|
DE602004029715D1
(de)
|
2003-12-23 |
2010-12-02 |
Astrazeneca Ab |
Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
WO2005061489A1
(en)
|
2003-12-24 |
2005-07-07 |
Prosidion Limited |
Heterocyclic derivatives as gpcr receptor agonists
|
WO2005067932A1
(en)
|
2004-01-06 |
2005-07-28 |
Janssen Pharmaceutica, N.V. |
(3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
|
ES2349195T3
(es)
|
2004-01-28 |
2010-12-28 |
F. Hoffmann-La Roche Ag |
Espiro-benzodioxoles y su uso como antagonistas de cb1.
|
BRPI0507309A
(pt)
|
2004-01-31 |
2007-06-26 |
Sanofi Aventis Deutschland |
derivados de ácido 7-fenilamino-4quinolon-3-carboxìlico, processos para produção e seu uso como medicamento
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
WO2005080361A1
(en)
|
2004-02-02 |
2005-09-01 |
Pfizer Products Inc. |
Histamine-3 receptor modulators
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
EP1718609A1
(en)
|
2004-02-17 |
2006-11-08 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted azetidine compounds, their preparation and use as medicaments
|
BRPI0507734A
(pt)
|
2004-02-18 |
2007-07-10 |
Astrazeneca Ab |
composto ou um sal, pró-droga ou solvato do mesmo, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
|
AU2005214084B2
(en)
|
2004-02-19 |
2010-06-03 |
Solvay Pharmaceuticals B.V. |
Imidazoline derivatives having CB1-antagonistic activity
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
EP1718617B1
(en)
|
2004-02-20 |
2009-08-19 |
AstraZeneca AB |
3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
|
EP1718671A2
(en)
|
2004-02-23 |
2006-11-08 |
Rheoscience A/S |
Peptide yy analogues
|
WO2005082893A2
(en)
|
2004-02-25 |
2005-09-09 |
Eli Lilly And Company |
Histamine h3 receptor antagonists, preparation and therapeutic uses
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
AU2005219779B2
(en)
|
2004-03-04 |
2011-04-14 |
Kissei Pharmaceutical Co., Ltd. |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
WO2005086904A2
(en)
|
2004-03-08 |
2005-09-22 |
Amgen Inc. |
Therapeutic modulation of ppar (gamma) activity
|
DK1751131T3
(da)
|
2004-03-10 |
2009-03-16 |
Janssen Pharmaceutica Nv |
MTP-inhiberende arylpiperidiner eller -piperaziner, der er substitueret med 5-leddede heterocykler
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
US20080255216A1
(en)
|
2004-03-29 |
2008-10-16 |
Aster Susan D |
Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
|
EP1586318A1
(en)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiadiazolidinones as GSK-3 inhibitors
|
US7608627B2
(en)
|
2004-04-05 |
2009-10-27 |
Takeda Pharmaceutical Company Limited |
6-azaindole compound
|
JPWO2005097738A1
(ja)
|
2004-04-06 |
2008-02-28 |
大日本住友製薬株式会社 |
新規スルホンアミド誘導体
|
JP2007532511A
(ja)
|
2004-04-09 |
2007-11-15 |
スミスクライン ビーチャム コーポレーション |
低用量医薬品
|
WO2005103039A1
(en)
|
2004-04-15 |
2005-11-03 |
Neurocrine Biosciences, Inc. |
2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
|
WO2005108370A1
(ja)
|
2004-04-16 |
2005-11-17 |
Ajinomoto Co., Inc. |
ベンゼン化合物
|
EP1747215A1
(en)
|
2004-05-12 |
2007-01-31 |
Aventis Pharmaceuticals, Inc. |
Substantially pure 2-{¬2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl|-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor
|
EP1604988A1
(en)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
JP2008504276A
(ja)
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
JPWO2006001318A1
(ja)
|
2004-06-24 |
2008-07-31 |
塩野義製薬株式会社 |
スルホンアミド化合物
|
KR20070041452A
(ko)
|
2004-06-24 |
2007-04-18 |
일라이 릴리 앤드 캄파니 |
이상지혈증 치료를 위한 화합물 및 방법
|
CN101001850A
(zh)
|
2004-06-24 |
2007-07-18 |
因塞特公司 |
酰胺基化合物及其作为药物的应用
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
DE102004034697A1
(de)
|
2004-07-17 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
BRPI0513864A
(pt)
|
2004-07-28 |
2008-05-20 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades
|
FR2873690B1
(fr)
|
2004-07-29 |
2006-10-13 |
Sanofi Synthelabo |
Derives d'oxopiperidine, leur preparation et leur application en therapeutique
|
FR2873693B1
(fr)
|
2004-07-29 |
2006-09-15 |
Sanofi Synthelabo |
Derives d'amino-tropane, leur preparation et leur application en therapeutique
|
DE102004037554A1
(de)
|
2004-08-03 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038270A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038268A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2575736A1
(en)
|
2004-08-06 |
2006-02-16 |
Merck & Co., Inc. |
Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
DE102004038269A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
WO2006016194A1
(en)
|
2004-08-12 |
2006-02-16 |
Prosidion Limited |
Substituted phenylacetamides and their use as glucokinase activators
|
DE102004039507A1
(de)
|
2004-08-14 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US20080261952A1
(en)
|
2004-08-16 |
2008-10-23 |
Jason Bloxham |
Aryl Urea Derivatives for Treating Obesity
|
EP1778250A2
(en)
|
2004-08-18 |
2007-05-02 |
Metabasis Therapeutics, Inc. |
Novel thiazole inhibitors of fructose 1,6-bisphosphatase
|
NZ553159A
(en)
|
2004-08-30 |
2010-05-28 |
Janssen Pharmaceutica Nv |
N-Adamantan-2-yl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
WO2006029699A1
(en)
|
2004-09-11 |
2006-03-23 |
Sanofi-Aventis Deutschland Gmbh |
7-azaindoles and their use as ppar agonists
|
WO2006058064A2
(en)
|
2004-11-29 |
2006-06-01 |
Merck & Co., Inc. |
Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
DE602005012292D1
(de)
|
2004-09-29 |
2009-02-26 |
Hoffmann La Roche |
Indozolonderivate als 11b-hsd1-inhibitoren
|
EP1803729A4
(en)
|
2004-09-29 |
2008-10-01 |
Kissei Pharmaceutical |
HETEROCYCLIC NITROGENIC COMPOUND 1- (-D-GLYCOPYRANOSYL) -3-SUBSTITUTED, THERAPEUTIC PREPARATION CONTAINING SAID COMPOUND, AND MEDICAL USE OF SAID COMPOUND
|
AU2005292134B2
(en)
|
2004-10-01 |
2010-12-23 |
Merck Sharp & Dohme Corp. |
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
EP1799711B1
(en)
|
2004-10-07 |
2012-06-20 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
JP2008515856A
(ja)
|
2004-10-07 |
2008-05-15 |
ノボ ノルディスク アクティーゼルスカブ |
遅延性glp−1化合物
|
CN101076524A
(zh)
|
2004-10-12 |
2007-11-21 |
法马科皮亚药物研发公司 |
作为选择性黑色素浓集激素受体拮抗剂的治疗肥胖和相关病症的双环化合物
|
EP1802623A1
(en)
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
EP1805180A1
(en)
|
2004-10-22 |
2007-07-11 |
SmithKline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
PT1807072E
(pt)
|
2004-10-29 |
2009-02-16 |
Lilly Co Eli |
Derivados de cicloalquil lactama como inibidores de 11- beta-hidroxi-esteróide desidrogenase 1
|
CA2585735A1
(en)
|
2004-11-02 |
2006-05-11 |
Pfizer Inc. |
Novel compounds of substituted and unsubstituted adamantyl amides
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
WO2006051662A1
(ja)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
チアゾール誘導体
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
JPWO2006059744A1
(ja)
|
2004-11-30 |
2008-06-05 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
ES2435790T3
(es)
|
2004-12-03 |
2013-12-23 |
Intervet International B.V. |
Piperazinas sustituidas como antagonistas de CB1
|
EP1824835A1
(en)
|
2004-12-03 |
2007-08-29 |
Novo Nordisk A/S |
Heteroaromatic glucokinase activators
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
WO2006065826A2
(en)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Process to chiral beta amino acid derivatives by asymmetric hydrogenation
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
EP1888544A2
(en)
|
2004-12-17 |
2008-02-20 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
JP2008524137A
(ja)
|
2004-12-18 |
2008-07-10 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
(5s)−3−[(s)−フルオロ(4−トリフルオロメチルフェニル)メチル−5,6,7,8−テトラヒドロキノリン−5−オール誘導体およびcetp阻害剤としてのそれらの使用
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
JP2008525404A
(ja)
|
2004-12-23 |
2008-07-17 |
アストラゼネカ アクチボラグ |
治療剤
|
US20080319019A1
(en)
|
2004-12-23 |
2008-12-25 |
Leifeng Cheng |
Therapeutic Agents
|
US8193359B2
(en)
|
2004-12-24 |
2012-06-05 |
Prosidion Limited |
G-protein coupled receptor agonists
|
MX2007007553A
(es)
|
2004-12-24 |
2007-08-15 |
Prosidion Ltd |
Agonistas del receptor acoplado a proteina g (gpr116) y uso de los mismos para tratar obesidad y diabetes.
|
KR20070090206A
(ko)
|
2004-12-24 |
2007-09-05 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
2환식 피롤 유도체
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
CA2605214C
(en)
|
2004-12-31 |
2016-07-12 |
Reddy Us Therapeutics, Inc. |
Benzylamine derivatives as cetp inhibitors
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
NZ555966A
(en)
|
2005-01-05 |
2011-03-31 |
Abbott Lab |
Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
WO2006073167A1
(ja)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
US7956061B2
(en)
|
2005-01-19 |
2011-06-07 |
Merck Sharp & Dohme Corp. |
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
JP2008528700A
(ja)
|
2005-02-03 |
2008-07-31 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Pparモジュレーターとしての化合物および組成物
|
EP1847531A4
(en)
|
2005-02-09 |
2009-04-22 |
Takeda Pharmaceutical |
PYRAZOLE DERIVATIVE
|
WO2006086562A2
(en)
|
2005-02-09 |
2006-08-17 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
DE602006009773D1
(de)
|
2005-02-11 |
2009-11-26 |
Lilly Co Eli |
Substituierte thiophenderivate als glucagonrezeptorantagonisten, herstellung und therapeutische anwendungen
|
EP1848699A1
(en)
|
2005-02-14 |
2007-10-31 |
Smithkline Beecham Corporation |
Anthranilic acid derivatives as hm74a receptor agonists
|
GB0503056D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
GB0503053D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
ES2358342T3
(es)
|
2005-02-15 |
2011-05-09 |
Kissei Pharmaceutical Co., Ltd. |
Compuesto 1-sustituido-7-(beta-d-glicopiranosiloxi)(aza)indol y composición farmacéutica comprendiendo el mismo.
|
RU2007128987A
(ru)
|
2005-02-15 |
2009-03-27 |
Ново Нордиск А/С (DK) |
3,4-дигидро-1н-изохинолин-2-карбоновой кислоты 5-аминопиридин-2-2-иловые эфиры
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
ZA200708144B
(en)
|
2005-02-25 |
2008-11-26 |
Takeda Pharmaceutical |
Pyridyl acetic acid compounds
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
EP1861416A1
(en)
|
2005-03-09 |
2007-12-05 |
The Board of Trustees of Leland Stanford Junior University |
Obestatin and its uses
|
DE602006003538D1
(de)
|
2005-03-09 |
2008-12-18 |
Hoffmann La Roche |
Benzothiazol-, thiazolopyridin-, benzooxazol- und oxazolopyridin-derivate als verbindungen zur behandlung von diabetes
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
US20090186834A1
(en)
|
2005-03-24 |
2009-07-23 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
TW200722432A
(en)
|
2005-03-25 |
2007-06-16 |
Sankyo Co |
Thiazole compounds
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
CN101151244B
(zh)
|
2005-04-01 |
2014-09-03 |
伊莱利利公司 |
组胺h3受体活性剂、制备和治疗用途
|
BRPI0609685A2
(pt)
|
2005-04-06 |
2010-04-20 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para tratamento e/ou profilaxia de enfermidades que estão associados com a modulação de receptores de cb1, e utilização dos mesmos
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
CN101160125A
(zh)
|
2005-04-13 |
2008-04-09 |
默克公司 |
烟酸受体激动剂、含有这样化合物的组合物和治疗方法
|
CA2605245A1
(en)
|
2005-04-15 |
2006-10-19 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP2008536950A
(ja)
|
2005-04-18 |
2008-09-11 |
ニューロジェン・コーポレーション |
置換ヘテロアリールのcb1拮抗薬
|
AU2006236226B2
(en)
|
2005-04-19 |
2012-07-05 |
Surface Logix, Inc. |
Inhibitors of microsomal triglyceride transfer protein and Apo-B secretion
|
WO2006111849A1
(en)
|
2005-04-20 |
2006-10-26 |
Pfizer Products Inc. |
Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
US20080194494A1
(en)
|
2005-04-26 |
2008-08-14 |
Microbia, Inc. |
4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
|
US20090131395A1
(en)
|
2005-05-05 |
2009-05-21 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
CA2607566A1
(en)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
WO2006122186A2
(en)
|
2005-05-10 |
2006-11-16 |
Microbia, Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
AU2006244043A1
(en)
|
2005-05-11 |
2006-11-16 |
Microbia, Inc. |
Processes for production of phenolic 4-biphenylylazetidin-2-ones
|
PL1881850T3
(pl)
|
2005-05-13 |
2011-03-31 |
Lilly Co Eli |
Pegylowane związki GLP-1
|
BRPI0610133A2
(pt)
|
2005-05-17 |
2010-06-01 |
Schering Corp |
heterociclos como agonistas de receptor de ácido nicotìnico para o tratamento de dislipidemia
|
WO2006127530A2
(en)
|
2005-05-25 |
2006-11-30 |
Merck & Co., Inc. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
US20090099355A1
(en)
|
2005-05-25 |
2009-04-16 |
Microbia, Inc. |
Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
AU2006255944B2
(en)
|
2005-06-08 |
2010-03-04 |
Japan Tobacco Inc. |
Heterocyclic compound
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005026808A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005026809A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
CN101198338A
(zh)
|
2005-06-15 |
2008-06-11 |
默克公司 |
抗高胆固醇血化合物
|
BRPI0611853A2
(pt)
|
2005-06-16 |
2010-10-05 |
Pfizer |
derivados de n-(piridin-2-il)-sulfonamida
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
US7605289B2
(en)
|
2005-06-17 |
2009-10-20 |
Amgen, Inc. |
Benzamide derivatives and uses related thereto
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
EP1928859A1
(en)
|
2005-06-17 |
2008-06-11 |
Carex SA |
Pyrazole derivates as cannabinoid receptor modulators
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
ES2353818T3
(es)
|
2005-06-22 |
2011-03-07 |
F. Hoffmann-La Roche Ag |
(6-fluor-benzo[1,3]dioxolil)-morfolin-4-il-metanonas y su uso como ligandos de cb1.
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057072A1
(es)
|
2005-06-22 |
2007-11-14 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
WO2007001939A1
(en)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
|
WO2007000445A1
(en)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
US20090203676A1
(en)
|
2005-06-30 |
2009-08-13 |
Oscar Barba |
G-protein Coupled Receptor Agonists
|
WO2007003960A1
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
WO2007003962A2
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
KR100979582B1
(ko)
|
2005-07-05 |
2010-09-01 |
에프. 호프만-라 로슈 아게 |
피리다진 유도체
|
US7999114B2
(en)
|
2005-07-08 |
2011-08-16 |
Novo Nordisk A/S |
Dicycloalkylcarbamoyl ureas as glucokinase activators
|
EP1904466A1
(en)
|
2005-07-08 |
2008-04-02 |
Novo Nordisk A/S |
Dicycloalkyl urea glucokinase activators
|
JPWO2007007688A1
(ja)
|
2005-07-08 |
2009-01-29 |
持田製薬株式会社 |
3,5−ジアミノ−1,2,4−トリアゾール誘導体
|
WO2007007040A1
(en)
|
2005-07-09 |
2007-01-18 |
Astrazeneca Ab |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
EP2027113A1
(en)
|
2005-07-09 |
2009-02-25 |
AstraZeneca AB |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
EP1902052B1
(en)
|
2005-07-09 |
2012-11-28 |
AstraZeneca AB |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
MX2008000560A
(es)
|
2005-07-11 |
2008-03-10 |
Mitsubishi Tanabe Pharma Corp |
Un derivado de oxima y sus preparaciones.
|
WO2007007910A1
(ja)
|
2005-07-13 |
2007-01-18 |
Banyu Pharmaceutical Co., Ltd. |
ヘテロ環置換ベンズイミダゾール誘導体
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
CA2615938C
(en)
|
2005-07-14 |
2014-04-29 |
Novo-Nordisk A/S |
Urea glucokinase activators
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
EP1757587A1
(en)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazoline compounds, their preparation and use as medicaments
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
ES2326952B1
(es)
|
2005-07-15 |
2010-05-28 |
Laboratorios Del Dr. Esteve, S.A. |
Hidratos de (rac) -n-piperidinil-5-(4-clorofenil)-1-(2,4-diclorofenil)4,5-dihidro-1h-pirazol-3-carboxamida.
|
US20090203581A1
(en)
|
2005-07-18 |
2009-08-13 |
Novo Nordisk A/S |
Novel Peptides for Use in the Treatment of Obesity
|
EP1910375B1
(en)
|
2005-07-19 |
2011-05-11 |
Merck Sharp & Dohme Corp. |
Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
|
ES2325558T3
(es)
|
2005-07-20 |
2009-09-08 |
Eli Lilly And Company |
Derivados de piridina como inhibidores de dipeptidilpeptidasa.
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
MX2008000885A
(es)
|
2005-07-21 |
2008-03-18 |
Hoffmann La Roche |
Compuestos de pirido[2,3-d]pirimidin-2,4-diamina como inhibidores de la proteina tirosina fosfatasa 1b.
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
WO2007017126A2
(en)
|
2005-07-29 |
2007-02-15 |
Laboratorios Del Dr. Esteve, S.A. |
POLYMORPH OF N-PIPERIDINYL-5- (4-CHLOROPHENYL) -1- (2, 4-DICHLOROPHENYL) -4, 5-DIHYDRO-lH-PYRAZOLE- 3 -CARBOXAMIDE AND ITS USE AS A CAMNABINOID RECEPTOR MODULATOR
|
JPWO2007013691A1
(ja)
|
2005-07-29 |
2009-02-12 |
武田薬品工業株式会社 |
スピロ環化合物
|
US7827993B2
(en)
|
2005-07-29 |
2010-11-09 |
Mayo Foundation For Medical Education And Research |
Skin pressure reduction to prevent decubitus ulcers by partial magnetic levitation
|
US8153694B2
(en)
|
2005-07-29 |
2012-04-10 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
ES2326357B1
(es)
|
2005-07-29 |
2010-04-21 |
Laboratorios Del Dr. Esteve, S.A. |
Fase amorfa de una pirazolina sustituida, su preparacion y su uso como medicamento.
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
WO2007016496A2
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
EP1912968A1
(en)
|
2005-08-04 |
2008-04-23 |
Pfizer Limited |
Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
|
EP1915355A1
(en)
|
2005-08-08 |
2008-04-30 |
AstraZeneca AB |
Therapeutic agents
|
CN101282954A
(zh)
|
2005-08-08 |
2008-10-08 |
阿斯利康(瑞典)有限公司 |
治疗剂
|
EP1915367A1
(en)
|
2005-08-09 |
2008-04-30 |
AstraZeneca AB |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
KR20080038396A
(ko)
|
2005-08-10 |
2008-05-06 |
스미스클라인 비참 코포레이션 |
선택적 hm74a 작동제로서의 크산틴 유도체
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
WO2007020502A2
(en)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Cannabinoid receptor ligands and uses thereof
|
EP1945635B1
(en)
|
2005-08-18 |
2009-05-06 |
F.Hoffmann-La Roche Ag |
Thiazolyl piperidine derivatives useful as h3 receptor modulators
|
JP5075125B2
(ja)
|
2005-08-26 |
2012-11-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療又は予防用ジペプチジルペプチダーゼiv阻害剤としての縮合アミノピペリジン
|
WO2007026215A1
(en)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
|
US20090258862A1
(en)
|
2005-08-29 |
2009-10-15 |
Colletti Steven L |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
JPWO2007026761A1
(ja)
|
2005-08-31 |
2009-03-12 |
アステラス製薬株式会社 |
チアゾール誘導体
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(en)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
US20080300251A1
(en)
|
2005-09-05 |
2008-12-04 |
Sattigeri Jitendra A |
Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
GB2429975A
(en)
|
2005-09-08 |
2007-03-14 |
Univ Edinburgh |
1,5-substituted-1H-tetrazole 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
MXPA05009633A
(es)
|
2005-09-08 |
2007-03-07 |
Silanes Sa De Cv Lab |
Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
|
WO2007033002A1
(en)
|
2005-09-14 |
2007-03-22 |
Amgen Inc. |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
CN101263140A
(zh)
|
2005-09-16 |
2008-09-10 |
阿斯利康(瑞典)有限公司 |
作为葡萄糖激酶活化剂的杂双环化合物
|
BRPI0616245A2
(pt)
|
2005-09-16 |
2011-06-14 |
Arena Pharm Inc |
modulador de metabolismo, seus usos, composiÇço farmaceutica compreendendo o mesmo, bem como mÉtodo para produÇço da referida composiÇço
|
JP2009508885A
(ja)
|
2005-09-21 |
2009-03-05 |
7ティーエム ファーマ エイ/エス |
治療的介入のためのy4選択性レセプターアゴニスト
|
WO2007038138A2
(en)
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
AU2005337101A1
(en)
|
2005-09-21 |
2007-04-12 |
7Tm Pharma A/S |
Y2 selective receptor agonists for therapeutic interventions
|
ATE458480T1
(de)
|
2005-09-23 |
2010-03-15 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl-pyrazol-cannabinoid- modulatoren
|
WO2007038045A1
(en)
|
2005-09-23 |
2007-04-05 |
Janssen Pharmaceutica, N.V. |
Tetrahydro-indazolyl cannabinoid modulators
|
JP4879988B2
(ja)
|
2005-09-29 |
2012-02-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
メラノコルチン−4受容体モジュレーターとしてのアシル化スピロピペリジン誘導体
|
AU2006299086A1
(en)
|
2005-09-29 |
2007-04-12 |
Sanofi-Aventis |
Phenyl- and pyridyl-1, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
|
JP2009510069A
(ja)
|
2005-09-30 |
2009-03-12 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としてのアシル化ピペリジン誘導体
|
US7799820B2
(en)
|
2005-09-30 |
2010-09-21 |
Banyu Pharmaceutical Co., Ltd. |
2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
JP2009513573A
(ja)
|
2005-09-30 |
2009-04-02 |
メルク エンド カムパニー インコーポレーテッド |
コレステリルエステル転送蛋白阻害剤
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
TW200745031A
(en)
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
US20070105819A1
(en)
|
2005-10-17 |
2007-05-10 |
Roger Olsson |
CB-1 modulating compounds and their use
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005049953A1
(de)
|
2005-10-19 |
2007-04-26 |
Sanofi-Aventis Deutschland Gmbh |
Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
AU2006304434B2
(en)
|
2005-10-20 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
AR056876A1
(es)
|
2005-10-21 |
2007-10-31 |
Tanabe Seiyaku Co |
Compuestos de pirazolo[1-5-a]pirimidina, antagonistas de receptores canabinoides cb1, composiciones farmaceuticas que los contienen y usos en el tratamiento de enfermedades del sistema nervioso central, tales como trastornos psicoticos, neurologicos y similares
|
JPWO2007049798A1
(ja)
|
2005-10-27 |
2009-04-30 |
萬有製薬株式会社 |
新規ベンゾオキサチイン誘導体
|
DE102005052101A1
(de)
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
CA2627910A1
(en)
|
2005-11-01 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
|
CN101355938A
(zh)
|
2005-11-01 |
2009-01-28 |
高点制药有限责任公司 |
取代的酰胺的药学应用
|
KR20080076916A
(ko)
|
2005-11-01 |
2008-08-20 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
WO2007053345A1
(en)
|
2005-11-01 |
2007-05-10 |
Array Biopharma Inc. |
Glucokinase activators
|
EP1948644A1
(en)
|
2005-11-03 |
2008-07-30 |
Prosidion Limited |
Tricyclo substituted amides
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
JP2009514836A
(ja)
|
2005-11-03 |
2009-04-09 |
プロシディオン・リミテッド |
トリシクロ置換型アミド
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
UA95613C2
(ru)
|
2005-11-09 |
2011-08-25 |
Уеллстат Терепьютикс Корпорейшн |
Соединения для лечения расстройсв метаболизма
|
JP2007131570A
(ja)
|
2005-11-09 |
2007-05-31 |
Mitsubishi Pharma Corp |
新規なアミノピロリジン誘導体
|
AU2006312557B2
(en)
|
2005-11-10 |
2011-12-08 |
Msd K.K. |
Aza-substituted spiro derivative
|
JP5107253B2
(ja)
|
2005-11-17 |
2012-12-26 |
イーライ リリー アンド カンパニー |
グルカゴン受容体アンタゴニスト、並びにその調製及び治療への使用
|
CN101312940B
(zh)
|
2005-11-17 |
2012-11-14 |
伊莱利利公司 |
胰高血糖素受体拮抗剂、制备和治疗用途
|
WO2007057768A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Sulfonyl derivatives
|
JP2009515997A
(ja)
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
JP2009515926A
(ja)
|
2005-11-18 |
2009-04-16 |
エフ.ホフマン−ラ ロシュ アーゲー |
アザインドール−2−カルボキサミド誘導体
|
GB0523609D0
(en)
|
2005-11-19 |
2005-12-28 |
Vernalis R&D Ltd |
Piperazine derivatives
|
EP1953145B1
(en)
|
2005-11-21 |
2015-11-04 |
Shionogi & Co., Ltd. |
Heterocyclic compound having inhibitory activity on 11-b-hydroxysteroid dehydrogenase type i
|
CN101312723B
(zh)
|
2005-11-22 |
2012-01-11 |
伊莱利利公司 |
胰高血糖素受体拮抗剂、制备和治疗用途
|
CA2630718A1
(en)
|
2005-11-22 |
2007-05-31 |
Amgen Inc. |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
DE102005055726A1
(de)
|
2005-11-23 |
2007-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
AU2006342059B2
(en)
|
2005-11-23 |
2012-05-10 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
WO2007060992A1
(ja)
|
2005-11-25 |
2007-05-31 |
Kaneka Corporation |
メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤
|
AR058199A1
(es)
|
2005-11-28 |
2008-01-23 |
Merck & Co Inc |
Derivados de 3- alquilazetidina sustituidos con heterociclos
|
WO2007064272A1
(en)
|
2005-11-29 |
2007-06-07 |
Astrazeneca Ab |
Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists
|
WO2007063928A1
(ja)
|
2005-11-30 |
2007-06-07 |
Toray Industries, Inc. |
新規な非環状アミンカルボキシアミド誘導体及びその塩
|
EP1959951B1
(en)
|
2005-12-01 |
2009-12-23 |
F. Hoffmann-la Roche AG |
Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
|
CN1978445B
(zh)
|
2005-12-02 |
2010-09-01 |
中国科学院上海药物研究所 |
一种可用作人源腺苷单核苷酸激活蛋白激酶激活剂的化合物及其制备方法和应用
|
UA94921C2
(en)
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
UA94724C2
(en)
|
2005-12-08 |
2011-06-10 |
Новартис Аг |
Thiadiazolidinone derivatives as antidiabetic agents
|
DE602006010433D1
(de)
|
2005-12-09 |
2009-12-24 |
Hoffmann La Roche |
Für die behandlung von obesitas geeignete tricyclische amidderivate
|
AU2006326540A1
(en)
|
2005-12-14 |
2007-06-21 |
Amgen Inc. |
Diaza heterocyclic sulfonamide derivatives and their uses
|
EP1962601B1
(en)
|
2005-12-14 |
2014-10-15 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
|
CA2633243C
(en)
|
2005-12-15 |
2014-05-27 |
Exelixis, Inc. |
Azepinoindole derivatives as pharmaceutical agents
|
JP2009519290A
(ja)
|
2005-12-15 |
2009-05-14 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピロロ[2,3−c]ピリジン誘導体
|
BRPI0619985A2
(pt)
|
2005-12-16 |
2011-10-25 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas, métodos para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, de obesidade e de diabetes do tipo ii em um ser humano ou animal e usos dos compostos
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
KR20150003157A
(ko)
|
2005-12-19 |
2015-01-08 |
트러스티즈 오브 터프츠 칼리지 |
소프트 단백질분해효소 억제자 및 이의 프로-소프트 폼
|
CA2633584A1
(en)
|
2005-12-20 |
2007-07-05 |
Takeda Pharmaceutical Company Limited |
Glucokinase activators
|
CA2633181A1
(en)
|
2005-12-21 |
2007-06-28 |
F. Hoffmann-La Roche Ag |
Salt and polymorph of dpp-iv inhibitor
|
WO2007075629A2
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
|
KR20070066988A
(ko)
|
2005-12-22 |
2007-06-27 |
크리스탈지노믹스(주) |
단백질 키나아제 활성을 저해하는 아미노 피리미딘유도체와 이의 제조방법 및 이를 유효성분으로 함유하는약학 조성물
|
BRPI0620468A2
(pt)
|
2005-12-22 |
2011-11-08 |
Transtech Pharma Inc |
ácidos fenóxi acéticos como ativadores de ppar delta
|
WO2007071738A1
(en)
|
2005-12-23 |
2007-06-28 |
Novartis Ag |
Condensed heterocyclic compounds useful as dpp-iv inhibitors
|
US20090156465A1
(en)
|
2005-12-30 |
2009-06-18 |
Sattigeri Jitendra A |
Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
|
WO2007081755A2
(en)
|
2006-01-09 |
2007-07-19 |
Metabasis Therapeutics, Inc. |
Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
|
UY30082A1
(es)
|
2006-01-11 |
2007-08-31 |
Boehringer Ingelheim Int |
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
|
CN100999517B
(zh)
|
2006-01-11 |
2010-12-15 |
北京摩力克科技有限公司 |
吡唑甲酰胺衍生物,药物组合物和其制备方法
|
AR058985A1
(es)
|
2006-01-13 |
2008-03-05 |
Schering Corp |
Diaril piperidinas como moduladores de cb1.
|
CA2635211A1
(en)
|
2006-01-13 |
2007-08-02 |
Merck & Co., Inc. |
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
EP1976840A1
(en)
|
2006-01-13 |
2008-10-08 |
F.Hoffmann-La Roche Ag |
Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
|
MX2008009354A
(es)
|
2006-01-18 |
2008-09-30 |
Schering Corp |
Moduladores de receptores cannabinoides.
|
RU2449999C2
(ru)
|
2006-01-18 |
2012-05-10 |
Эвольва Са |
Модуляторы ppar
|
WO2007133820A2
(en)
|
2006-01-19 |
2007-11-22 |
Neurogen Corporation |
Diaryl triazolones as cb1 antagonists
|
BRPI0706654A2
(pt)
|
2006-01-20 |
2011-04-05 |
Smithkline Beecham Corp |
composição farmacêutica, método para tratar condições ou distìrbios em um mamìfero, uso de um composto, e, composto
|
US20090170847A1
(en)
|
2006-01-23 |
2009-07-02 |
Seung Chul Lee |
Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same
|
ATE479656T1
(de)
|
2006-01-23 |
2010-09-15 |
Hoffmann La Roche |
Cyclohexyl-sulfonamid-derivate mit h3- rezeptoraktivität
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
CN101007804B
(zh)
|
2006-01-25 |
2011-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
1,3-苯并间二氧杂环戊烯-2,2-二羧酸衍生物、其制备方法和医疗用途
|
EP1978804B1
(en)
|
2006-01-25 |
2014-07-30 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
WO2007089512A1
(en)
|
2006-01-27 |
2007-08-09 |
Array Biopharma Inc. |
Glucokinase activators
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
RU2008135126A
(ru)
|
2006-01-30 |
2010-03-10 |
Айрм Ллк (Bm) |
Полициклические производные тетрагидроизохинолина и содержащие их композиции в качестве модуляторов ppar
|
KR20080086529A
(ko)
|
2006-01-30 |
2008-09-25 |
아이알엠 엘엘씨 |
Ppar 조절제로서의 화합물 및 조성물
|
PL1979355T3
(pl)
|
2006-01-30 |
2011-04-29 |
Irm Llc |
Pochodne spiro imidazoli jako modulatory PPAR
|
WO2007086080A2
(en)
|
2006-01-30 |
2007-08-02 |
Glenmark Pharmaceuticals Limited |
NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
UY30117A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compuesto amina trisustituido
|
US20070197530A1
(en)
|
2006-01-31 |
2007-08-23 |
Yun-Long Li |
Amido compounds and their use as pharmaceuticals
|
PE20071025A1
(es)
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
FR2896799B1
(fr)
|
2006-02-02 |
2008-03-28 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
EP1816125A1
(en)
|
2006-02-02 |
2007-08-08 |
Ranbaxy Laboratories, Ltd. |
Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
|
US7863302B2
(en)
|
2006-02-03 |
2011-01-04 |
Eli Lilly And Company |
Compounds and methods for modulating FX-receptors
|
US7745477B2
(en)
|
2006-02-07 |
2010-06-29 |
Hoffman-La Roche Inc. |
Heteroaryl and benzyl amide compounds
|
US7691876B2
(en)
|
2006-02-07 |
2010-04-06 |
Hoffmann-La Roche Inc. |
Heterobicyclic amide compounds
|
US7678818B2
(en)
|
2006-02-07 |
2010-03-16 |
Hoffmann-La Roche Inc. |
Anthranilamide and 2-amino-heteroarene-carboxamide compounds
|
PA8713501A1
(es)
|
2006-02-07 |
2009-09-17 |
Wyeth Corp |
INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1
|
ATE500222T1
(de)
|
2006-02-07 |
2011-03-15 |
Hoffmann La Roche |
Benzamid- und heteroarenderivate als cetp- inhibitoren
|
US7572823B2
(en)
|
2006-02-07 |
2009-08-11 |
Hoffmann-La Roche Inc. |
Heteroaryl carboxamide compounds
|
US20090076049A1
(en)
|
2006-02-07 |
2009-03-19 |
Astrazeneca Ab |
Novel Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1
|
WO2007092364A2
(en)
|
2006-02-07 |
2007-08-16 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
WO2007094962A2
(en)
|
2006-02-09 |
2007-08-23 |
Athersys, Inc. |
Pyrazoles for the treatment of obesity and other cns disorders
|
CA2642159A1
(en)
|
2006-02-10 |
2007-08-16 |
Gunderboom, Inc. |
Filter cartridges for fluid intake systems
|
EP1983972A4
(en)
|
2006-02-13 |
2012-01-25 |
Wellstat Therapeutics Corp |
COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
|
WO2007095513A1
(en)
|
2006-02-14 |
2007-08-23 |
Janssen Pharmaceutica, Nv |
Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators
|
DE102006006648A1
(de)
|
2006-02-14 |
2007-08-23 |
Merck Patent Gmbh |
Mandelsäurehydrazide
|
JP2010517931A
(ja)
|
2006-02-14 |
2010-05-27 |
インターセプト ファーマシューティカルズ, インコーポレイテッド |
Fxr媒介性の疾患または状態の予防または治療用のfxrリガンドとしての胆汁酸誘導体
|
US20070219258A1
(en)
|
2006-02-15 |
2007-09-20 |
Keyes Robert F |
Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
JP2009526868A
(ja)
|
2006-02-15 |
2009-07-23 |
アボット・ラボラトリーズ |
新規なアセチル−CoAカルボキシラーゼ(ACC)阻害薬およびこれらの糖尿病、肥満および代謝症候群における使用
|
EP1989191B1
(en)
|
2006-02-15 |
2011-07-20 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
AU2007218053B2
(en)
|
2006-02-15 |
2010-05-27 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
ITRM20060090A1
(it)
|
2006-02-22 |
2007-08-23 |
Sigma Tau Ind Farmaceuti |
Nuovi composti inibitori cpt a livello del snc come farmaci antidiabetici e o antiobesita
|
WO2007096186A1
(en)
|
2006-02-23 |
2007-08-30 |
Santhera Pharmaceuticals (Schweiz) Ag |
Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
US8138188B2
(en)
|
2006-02-23 |
2012-03-20 |
Pfizer Inc. |
Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
|
US7728031B2
(en)
|
2006-02-24 |
2010-06-01 |
Abbott Laboratories |
Octahydro-pyrrolo[3,4-b]pyrrole derivatives
|
WO2007100833A2
(en)
|
2006-02-24 |
2007-09-07 |
Wyeth |
Gpat4 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase
|
US20080038278A1
(en)
|
2006-02-24 |
2008-02-14 |
Jingsong Cao |
GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
US8268867B2
(en)
|
2006-02-27 |
2012-09-18 |
Cadila Healthcare Limited |
1,3-dioxane carboxylic acids
|
ATE530066T1
(de)
|
2006-02-28 |
2011-11-15 |
Wellstat Therapeutics Corp |
Verbindungen zur behandlung von stoffwechselstörungen
|
WO2007099385A1
(en)
|
2006-03-01 |
2007-09-07 |
Glenmark Pharmaceuticals S.A. |
Dipeptidyl peptidase iv inhibitor compounds and compositions
|
JP2007230909A
(ja)
|
2006-03-01 |
2007-09-13 |
Univ Of Tokyo |
置換イソキサゾール誘導体
|
US7834178B2
(en)
|
2006-03-01 |
2010-11-16 |
Bristol-Myers Squibb Company |
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
|
WO2007100027A1
(ja)
|
2006-03-02 |
2007-09-07 |
Daiichi Sankyo Company, Limited |
光学活性なチアゾリジンジオン誘導体
|
WO2007101270A1
(en)
|
2006-03-02 |
2007-09-07 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
EP1993543A2
(en)
|
2006-03-03 |
2008-11-26 |
Merck & Co., Inc. |
Novel crystalline forms of antidiabetic compounds
|
US20070208001A1
(en)
|
2006-03-03 |
2007-09-06 |
Jincong Zhuo |
Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
US20080051452A1
(en)
|
2006-03-06 |
2008-02-28 |
Avestha Gengraine Technologies Pvt. Ltd. |
Hexanoic acid derivatives as dipeptidyl peptidase inhibitors
|
US20070270492A1
(en)
|
2006-03-06 |
2007-11-22 |
Avestha Gengraine Technologies Pvt. Ltd. |
Nananoic acid derivatives as dipeptidyl peptidase inhibitors
|
JP2009132620A
(ja)
|
2006-03-07 |
2009-06-18 |
Astellas Pharma Inc |
フェニルチアゾール誘導体
|
TW200800979A
(en)
|
2006-03-07 |
2008-01-01 |
Lundbeck & Co As H |
Halogenated sulfonamide derivatives
|
JP5302012B2
(ja)
|
2006-03-08 |
2013-10-02 |
タケダ カリフォルニア インコーポレイテッド |
グルコキナーゼ活性剤
|
CA2645719A1
(en)
|
2006-03-09 |
2007-09-13 |
High Point Pharmaceuticals, Llc |
Compounds that modulate ppar activity, their preparation and use
|
ZA200807715B
(en)
|
2006-03-09 |
2009-11-25 |
Pharmacopeia Inc |
9-Heteroarylpurine MNK2 inhibitors for treating metabolic disorders
|
AU2007226673A1
(en)
|
2006-03-10 |
2007-09-20 |
Jenrin Discovery |
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
|
ATE494782T1
(de)
|
2006-03-10 |
2011-01-15 |
Neurogen Corp |
Piperazinyl-oxoalkyl-tetrahydroisochinoline und verwandte analoga
|
WO2007105650A1
(ja)
|
2006-03-10 |
2007-09-20 |
Ajinomoto Co., Inc. |
4-ヒドロキシイソロイシン誘導体および同誘導体の製造方法
|
EP2007749A2
(en)
|
2006-03-13 |
2008-12-31 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
WO2007106469A2
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
US8486890B2
(en)
|
2006-03-15 |
2013-07-16 |
Novo Nordisk A/S |
Amylin derivatives
|
ZA200807451B
(en)
|
2006-03-16 |
2010-01-27 |
Astellas Pharma Inc |
A triazole derivative or salt thereof
|
EP1834641A1
(en)
|
2006-03-16 |
2007-09-19 |
Sanofi-Aventis |
Use of CRF1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
|
JP5243696B2
(ja)
|
2006-03-17 |
2013-07-24 |
田辺三菱製薬株式会社 |
ベンゼン誘導体
|
DE102006012548A1
(de)
|
2006-03-18 |
2007-09-20 |
Bayer Healthcare Ag |
Substituierte Chromanol-Derivate und ihre Verwendung
|
US20100168083A1
(en)
|
2006-03-21 |
2010-07-01 |
Soren Ebdrup |
Adamantane derivatives for the treatment of the metabolic syndrome
|
JP5031817B2
(ja)
|
2006-03-22 |
2012-09-26 |
エフ.ホフマン−ラ ロシュ アーゲー |
11β−HSD1としてのピラゾール
|
MX2008012185A
(es)
|
2006-03-23 |
2008-10-02 |
Inotek Pharmaceuticals Corp |
Compuestos de purina y metodos de uso de los mismos.
|
AU2007231594A1
(en)
|
2006-03-23 |
2007-10-04 |
Amgen Inc. |
1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
CA2645639A1
(en)
|
2006-03-23 |
2007-10-04 |
Merck & Co. Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
FR2898894B1
(fr)
|
2006-03-24 |
2008-06-06 |
Genfit Sa |
Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
|
FR2898892A1
(fr)
|
2006-03-24 |
2007-09-28 |
Genfit Sa |
Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
|
WO2007117381A2
(en)
|
2006-03-24 |
2007-10-18 |
Array Biopharma Inc. |
2 -aminopyridine analogs as glucokinase activators
|
JP2007291075A
(ja)
|
2006-03-27 |
2007-11-08 |
Sankyo Co Ltd |
新規化合物ステレニン及びその製造方法
|
US20070254911A1
(en)
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
WO2007112402A1
(en)
|
2006-03-27 |
2007-10-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
|
TW200806669A
(en)
|
2006-03-28 |
2008-02-01 |
Merck & Co Inc |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
AU2007229637A1
(en)
|
2006-03-28 |
2007-10-04 |
Novartis Ag |
Amide derivatives and their application for the treatment of G protein related diseases
|
NZ570524A
(en)
|
2006-03-28 |
2011-08-26 |
High Point Pharmaceuticals Llc |
Benzothiazoles having histamine H3 receptor activity
|
DE102006014685A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
DE102006014688A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
WO2007126934A2
(en)
|
2006-03-29 |
2007-11-08 |
Merck & Co., Inc. |
Amidoethylthioether orexin receptor antagonists
|
AU2007245037A1
(en)
|
2006-03-29 |
2007-11-08 |
Merck Sharp & Dohme Corp. |
Diazepan orexin receptor antagonists
|
GB0606429D0
(en)
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
CN101454327A
(zh)
|
2006-03-30 |
2009-06-10 |
Irm责任有限公司 |
作为大麻素1活性抑制剂的吡咯并嘧啶类化合物
|
JP2009532379A
(ja)
|
2006-03-31 |
2009-09-10 |
ノバルティス アクチエンゲゼルシャフト |
PTPaseのチアジアゾリジノン阻害剤
|
SI2007752T1
(sl)
|
2006-03-31 |
2010-12-31 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-il pirimidini in pirazini kot modulatorji histamin H4 receptorja
|
EP2004643A1
(en)
|
2006-03-31 |
2008-12-24 |
Novartis AG |
Organic compounds
|
US7851654B2
(en)
|
2006-04-03 |
2010-12-14 |
Industry-Academic Cooperation Foundation Gyeongsang National University |
Chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof
|
US7645748B2
(en)
|
2006-04-03 |
2010-01-12 |
Forbes Medi-Tech Inc. |
Sterol/stanol phosphorylnitroderivatives and use thereof
|
WO2007113634A1
(en)
|
2006-04-03 |
2007-10-11 |
Matrix Laboratories Ltd. |
Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
|
CN101050194B
(zh)
|
2006-04-05 |
2013-08-21 |
上海恒瑞医药有限公司 |
双环辛烷类衍生物、其制备方法及其在医药上的用途
|
WO2007116229A1
(en)
|
2006-04-06 |
2007-10-18 |
Prosidion Limited |
Heterocyclic gpcr agonists
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
BRPI0710669A2
(pt)
|
2006-04-07 |
2011-08-16 |
High Point Pharmaceuticals Llc |
compostos ativos de dehidrogenase de 11b-hidroxiesteróide tipo 1
|
EP1842846A1
(en)
|
2006-04-07 |
2007-10-10 |
Santhera Pharmaceuticals (Schweiz) AG |
Phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
KR20090047391A
(ko)
|
2006-04-07 |
2009-05-12 |
데벨로겐 악틴게젤샤프트 |
약제학적 조성물을 위한 Mnk1/Mnk2 억제 활성을 갖는티에노피리미딘
|
US20100029716A1
(en)
|
2006-04-10 |
2010-02-04 |
Concert Pharmaceuticals, Inc. |
Novel 1,2,3,4- tetrahydroquinoline derivatives
|
MX2008013137A
(es)
|
2006-04-11 |
2008-10-21 |
Novartis Ag |
Compuestos organicos.
|
CA2648642A1
(en)
|
2006-04-11 |
2007-10-25 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
CN101460453B
(zh)
|
2006-04-11 |
2012-10-03 |
埃科特莱茵药品有限公司 |
磺酰胺化合物
|
GB0607196D0
(en)
|
2006-04-11 |
2006-05-17 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
WO2007116092A1
(en)
|
2006-04-12 |
2007-10-18 |
Probiodrug Ag |
Enzyme inhibitors
|
JP2009533375A
(ja)
|
2006-04-12 |
2009-09-17 |
エフ.ホフマン−ラ ロシュ アーゲー |
5−アミド−2−カルボキサミドインドール類
|
CA2649302A1
(en)
|
2006-04-12 |
2007-10-25 |
Wyeth |
Anilino-pyrimidine phenyl and benzothiophene analogs
|
EP2015769A4
(en)
|
2006-04-13 |
2013-12-25 |
Ipsen Pharma |
PHARMACEUTICAL COMPOSITIONS OF HGLP-1, EXENDINE 4 AND THEIR ANALOGUES
|
JP2007284090A
(ja)
|
2006-04-14 |
2007-11-01 |
Dic Plastics Inc |
蓋体の係止構造および容器
|
EP2009011A1
(en)
|
2006-04-14 |
2008-12-31 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing heterocyclic compound
|
WO2007119837A1
(ja)
|
2006-04-14 |
2007-10-25 |
Ajinomoto Co., Inc. |
リパーゼ阻害剤
|
FR2899899A1
(fr)
|
2006-04-14 |
2007-10-19 |
Sanofi Aventis Sa |
Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique
|
CN102643248A
(zh)
|
2006-04-18 |
2012-08-22 |
日本化学医药株式会社 |
过氧化物酶体增殖剂激活受体δ的激活剂
|
PE20080188A1
(es)
|
2006-04-18 |
2008-03-10 |
Janssen Pharmaceutica Nv |
Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol
|
WO2007120102A1
(en)
|
2006-04-19 |
2007-10-25 |
Astrazeneca Ab |
New substituted oxindole derivatives
|
WO2007122970A1
(ja)
|
2006-04-20 |
2007-11-01 |
Osaka University |
核内受容体に結合するリガンド
|
EP2573111A1
(en)
|
2006-04-20 |
2013-03-27 |
Amgen Inc. |
GLP-1 compounds
|
NL2000581C2
(nl)
|
2006-04-20 |
2008-01-03 |
Pfizer Prod Inc |
Aangecondenseerde fenylamidoheterocyclische verbindingen.
|
ES2533263T3
(es)
|
2006-04-21 |
2015-04-08 |
Eli Lilly And Company |
Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
|
AU2007240458B2
(en)
|
2006-04-21 |
2012-03-15 |
Eli Lilly And Company |
Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
|
GB0607951D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607954D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
AU2007240450B2
(en)
|
2006-04-21 |
2011-12-22 |
Eli Lilly And Company |
Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
GB0607953D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
WO2007123949A2
(en)
|
2006-04-21 |
2007-11-01 |
Schering Corporation |
Cannabinoid receptor modulators
|
WO2007122634A2
(en)
|
2006-04-24 |
2007-11-01 |
Jubilant Biosys Limited |
Pyrimidinediones as tyrosine kinase inhibitors
|
ATE473210T1
(de)
|
2006-04-24 |
2010-07-15 |
Lilly Co Eli |
Substituierte pyrrolidinone als hemmer von 11- beta-hydroxysteroiddehydrogenase 1
|
AU2007244971B2
(en)
|
2006-04-24 |
2012-01-19 |
Eli Lilly And Company |
Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
UA94741C2
(en)
|
2006-04-24 |
2011-06-10 |
Эли Лилли Энд Компани |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
DE602007004324D1
(en)
|
2006-04-25 |
2010-03-04 |
Lilly Co Eli |
11-beta-hydroxysteroid-dehydrogenase-1-hemmer
|
ES2429570T3
(es)
|
2006-04-25 |
2013-11-15 |
Eli Lilly And Company |
Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
|
US7659281B2
(en)
|
2006-04-25 |
2010-02-09 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors
|
JP5324427B2
(ja)
|
2006-04-25 |
2013-10-23 |
イーライ リリー アンド カンパニー |
11−β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
|
CN101432285A
(zh)
|
2006-04-26 |
2009-05-13 |
埃科特莱茵药品有限公司 |
作为食欲素受体拮抗剂的吡唑并-四氢吡啶衍生物
|
WO2007121687A1
(fr)
|
2006-04-26 |
2007-11-01 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China |
Dérivés du 4-méthyl-1h-diaryl pyrazole et leur utilisation comme médicaments
|
WO2007122411A1
(en)
|
2006-04-26 |
2007-11-01 |
Astrazeneca Ab |
Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome
|
US20070254863A1
(en)
|
2006-04-27 |
2007-11-01 |
Jochen Antel |
Use of CBx cannabinoid receptor modulators as potassium channel modulators
|
WO2007126043A1
(ja)
|
2006-04-27 |
2007-11-08 |
Mitsubishi Tanabe Pharma Corporation |
チアゾール環を含むカルボン酸誘導体の医薬用途
|
AR060623A1
(es)
|
2006-04-27 |
2008-07-02 |
Astrazeneca Ab |
Compuestos derivados de 2-azetidinona y un metodo de preparacion
|
EP1849785A1
(en)
|
2006-04-28 |
2007-10-31 |
Neuropharma, S.A. |
N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
|
WO2007127901A1
(en)
|
2006-04-28 |
2007-11-08 |
Eli Lilly And Company |
Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
US9150507B2
(en)
|
2006-04-28 |
2015-10-06 |
Shionogi & Co., Ltd. |
Amine derivative having NPY Y5 receptor antagonistic activity
|
CA2649577A1
(en)
|
2006-04-28 |
2007-11-08 |
Transtech Pharma, Inc. |
Benzamide glucokinase activators
|
DE602007010764D1
(en)
|
2006-04-28 |
2011-01-05 |
Transtech Pharma Inc |
Benzamidglucokinaseaktivatoren
|
CA2649677A1
(en)
|
2006-05-01 |
2007-11-15 |
Incyte Corporation |
Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
|
JP2009167104A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
フェニル5−チオグリコシド化合物
|
EP1854806A1
(en)
|
2006-05-02 |
2007-11-14 |
MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Thioglycosides as pharmaceutically active agents
|
JP2009167103A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
ピラゾリル5−チオグリコシド化合物
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
NZ619413A
(en)
|
2006-05-04 |
2015-08-28 |
Boehringer Ingelheim Int |
Polymorphs of a dpp-iv enzyme inhibitor
|
AU2007258117B2
(en)
|
2006-05-05 |
2013-05-30 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating gene expression
|
CA2651385C
(en)
|
2006-05-05 |
2015-02-03 |
John F. Mcelroy |
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
|
WO2007128801A1
(en)
|
2006-05-08 |
2007-11-15 |
Novartis Ag |
Combination of organic compounds
|
US20080247964A1
(en)
|
2006-05-08 |
2008-10-09 |
Yuelian Xu |
Substituted azaspiro derivatives
|
US8796205B2
(en)
|
2006-05-09 |
2014-08-05 |
Novo Nordisk A/S |
Insulin derivative
|
KR101441444B1
(ko)
|
2006-05-09 |
2014-09-18 |
노보 노르디스크 에이/에스 |
인슐린 유도체
|
US8232403B2
(en)
|
2006-05-10 |
2012-07-31 |
Novartis Ag |
Bicyclic derivatives as CETP inhibitors
|
US20120088746A1
(en)
|
2006-05-10 |
2012-04-12 |
Pfizer Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
WO2007129188A1
(en)
|
2006-05-10 |
2007-11-15 |
Pfizer Japan Inc. |
Cyclopropanecarboxamide compound
|
BRPI0711416A2
(pt)
|
2006-05-11 |
2011-11-01 |
Sanofi Aventis |
ácidos carboxìlicos substituìdos com 4,5-difenil pirimidinila, processo para a produção e uso dos mesmos como medicamentos
|
WO2007134149A2
(en)
|
2006-05-11 |
2007-11-22 |
Janssen Pharmaceutica N.V. |
3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP2009536953A
(ja)
|
2006-05-11 |
2009-10-22 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Cetp阻害剤としての1,2,3,4−テトラヒドロ−キノリン誘導体
|
DE102006021872B4
(de)
|
2006-05-11 |
2008-04-17 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CN101443324A
(zh)
|
2006-05-11 |
2009-05-27 |
诺瓦提斯公司 |
作为cetp抑制剂的苄胺衍生物
|
DE102006021874B4
(de)
|
2006-05-11 |
2008-03-27 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7851468B2
(en)
|
2006-05-15 |
2010-12-14 |
Cephalon, Inc. |
Substituted pyrazolo[3,4-d]pyrimidines
|
TW200812588A
(en)
|
2006-05-15 |
2008-03-16 |
Neurogen Corp |
CRF1 receptor ligands comprising heteroaryl fused bicycles
|
PE20080069A1
(es)
|
2006-05-15 |
2008-02-22 |
Merck & Co Inc |
Compuestos biciclicos como agonistas del receptor 40 acoplado a proteina g (gpr40)
|
CA2651777A1
(en)
|
2006-05-15 |
2007-11-29 |
Merck & Co., Inc. |
Pro-drugs of tertiary alcohols
|
US7935713B2
(en)
|
2006-05-16 |
2011-05-03 |
Merck Sharp & Dohme Corp. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
JP5167250B2
(ja)
|
2006-05-16 |
2013-03-21 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療又は予防のためのジペプチジルペプチダーゼiv阻害剤としてのアミノテトラヒドロピラン
|
US7432255B2
(en)
|
2006-05-16 |
2008-10-07 |
Hoffmann-La Roche Inc. |
1H-indol-5-yl-piperazin-1-yl-methanone derivatives
|
CA2652375A1
(en)
|
2006-05-17 |
2007-11-29 |
Incyte Corporation |
Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
|
EP2024334A4
(en)
|
2006-05-18 |
2009-09-30 |
Merck & Co Inc |
SUBSTITUTED ESTERS AS CANNABINOID-1 RECEPTOR MODULATORS
|
WO2007134958A1
(en)
|
2006-05-18 |
2007-11-29 |
F. Hoffmann-La Roche Ag |
Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
|
EP2019673A4
(en)
|
2006-05-18 |
2010-06-16 |
Wellstat Therapeutics Corp |
COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
|
MX2008014512A
(es)
|
2006-05-19 |
2008-11-27 |
Taisho Pharma Co Ltd |
Compuesto de c-fenil glucitol para el tratamiento de diabetes.
|
AU2007254232A1
(en)
|
2006-05-19 |
2007-11-29 |
Wyeth |
N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
|
EP2038256A1
(en)
|
2006-05-23 |
2009-03-25 |
TransTech Pharma, Inc |
6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament
|
EP2019679B1
(en)
|
2006-05-23 |
2018-06-20 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
WO2007134986A1
(en)
|
2006-05-23 |
2007-11-29 |
F. Hoffmann-La Roche Ag |
Pyridopyrimidinone derivatives
|
WO2007135427A1
(en)
|
2006-05-23 |
2007-11-29 |
Astrazeneca Ab |
1,4-disubstituted piperazine and 1,4-disubstituted azepane as 11 -beta-hydroxysteroid dehydrogenase 1 inhibitors
|
CL2007001451A1
(es)
|
2006-05-24 |
2008-01-11 |
Eli Lilly And Company Soc Organizada Bajo Las Leyes Del Estado De Indiana |
Compuestos derivados de [1,2,3]-tiazol-4-ilmetoxilo, agonista del receptor farnesoide x (fxr); composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dislipidemia y enfermedades relacionadas.
|
JP5119241B2
(ja)
|
2006-05-24 |
2013-01-16 |
イーライ リリー アンド カンパニー |
Fxrアゴニスト
|
JP5105297B2
(ja)
|
2006-05-25 |
2012-12-26 |
味の素株式会社 |
Ppar活性調節剤
|
MY147954A
(en)
|
2006-05-26 |
2013-02-15 |
Nestec Sa |
Methods of use and nutritional compositions of touchi extract
|
WO2007140005A2
(en)
|
2006-05-26 |
2007-12-06 |
Janssen Pharmaceutica N.V. |
Oxazolyl piperidine modulators of fatty acid amide hydrolase
|
JP2009538323A
(ja)
|
2006-05-26 |
2009-11-05 |
ノバルティス アクチエンゲゼルシャフト |
アルドステロン合成酵素および/または11β−ヒドロキシラーゼ阻害剤
|
TW200806625A
(en)
|
2006-05-26 |
2008-02-01 |
Astrazeneca Ab |
Therapeutic compounds
|
ATE538116T1
(de)
|
2006-05-29 |
2012-01-15 |
High Point Pharmaceuticals Llc |
3-(1,3-benyodioxol-5-yl)-6- (4- cyclopropylpiperazin-1-yl)-pyridazin, dessen salze und solvate und dessen verwendung als histamin-h3-rezeptorantagonist
|
US7902184B2
(en)
|
2006-05-30 |
2011-03-08 |
Hoffmann-La Roche Inc. |
Piperazinyl pyrimidine derivatives
|
CN101495456B
(zh)
|
2006-05-30 |
2014-03-19 |
詹森药业有限公司 |
作为组胺h3受体的调节剂的取代的吡啶基酰胺化合物
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
EP2024349B1
(en)
|
2006-05-31 |
2017-08-02 |
AbbVie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
WO2007140385A2
(en)
|
2006-05-31 |
2007-12-06 |
Abbott Laboratories |
Thiazole compounds as cannabinoid receptor ligands and uses thereof
|
WO2007138050A1
(en)
|
2006-05-31 |
2007-12-06 |
Solvay Pharmaceuticals B.V. |
Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
|
EP2049518B1
(en)
|
2006-05-31 |
2011-08-31 |
Takeda San Diego, Inc. |
Indazole and isoindole derivatives as glucokinase activating agents.
|
EP2032548A1
(en)
|
2006-06-01 |
2009-03-11 |
F.Hoffmann-La Roche Ag |
Thiazole derivatives
|
AU2007254827A1
(en)
|
2006-06-02 |
2007-12-13 |
San Diego State University Research Foundation |
Compositions and methods for ameliorating hyperlipidemia
|
JP2009190971A
(ja)
|
2006-06-06 |
2009-08-27 |
Mitsubishi Tanabe Pharma Corp |
2−シアノピロリジン誘導体
|
FR2901792A1
(fr)
|
2006-06-06 |
2007-12-07 |
Negma Lerads Soc Par Actions S |
DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
|
US20070287674A1
(en)
|
2006-06-08 |
2007-12-13 |
Hej Research Institute Of Chemistry |
New treatment of diabetes mellitus
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
EP2029540B1
(en)
|
2006-06-08 |
2010-08-04 |
Amgen Inc. |
Benzamide derivatives and uses related thereto
|
AU2007255366B2
(en)
|
2006-06-09 |
2013-07-18 |
Synact Pharma Aps |
Phenyl pyrrole aminoguanidine derivatives
|
US20080051387A1
(en)
|
2006-06-09 |
2008-02-28 |
Yuelian Xu |
Tetrahydropyrido[3,4-d]pyrimidines and related analogues
|
WO2007146761A2
(en)
|
2006-06-12 |
2007-12-21 |
Neurogen Corporation |
Diaryl pyrimidinones and related compounds
|
WO2008035359A2
(en)
|
2006-06-12 |
2008-03-27 |
Cadila Healthcare Limited |
Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
|
CA2655282A1
(en)
|
2006-06-16 |
2007-12-21 |
High Point Pharmaceuticals, Llc |
Pharmaceutical use of substituted piperidine carboxamides
|
US20100048714A1
(en)
|
2006-06-19 |
2010-02-25 |
University Of Utah Research Foundation |
Methods and Compositions Related to Inhibition of Ceramide Synthesis
|
US7629346B2
(en)
|
2006-06-19 |
2009-12-08 |
Hoffmann-La Roche Inc. |
Pyrazinecarboxamide derivatives as CB1 antagonists
|
US20100234439A1
(en)
|
2006-06-20 |
2010-09-16 |
Leifeng Cheng |
Therapeutic agents
|
CN101472897A
(zh)
|
2006-06-20 |
2009-07-01 |
阿斯利康(瑞典)有限公司 |
治疗剂
|
WO2007148185A2
(en)
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
WO2008001160A1
(en)
|
2006-06-23 |
2008-01-03 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
AU2007260851B2
(en)
|
2006-06-23 |
2013-01-17 |
Incyte Corporation |
Purinone derivatives as HM74a agonists
|
WO2007150026A2
(en)
|
2006-06-23 |
2007-12-27 |
Incyte Corporation |
Purinone derivatives as hm74a agonists
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
WO2008002575A1
(en)
|
2006-06-26 |
2008-01-03 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
TW200815418A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds I
|
CN101096363B
(zh)
|
2006-06-27 |
2011-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途
|
TW200815417A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds II
|
SI2040713T1
(sl)
|
2006-06-27 |
2014-11-28 |
Intercept Pharmaceuticals, Inc. |
Derivati žolčne kisline kot FXR ligandi za preprečevanje ali zdravljenje bolezni ali stanj, posredovanih s FXR
|
TW200811158A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Piperidine or pyrrolidine urea derivatives, their preparation and their therapeutic application
|
TW200811170A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Urea derivatives of tropane, their preparation and their therapeutic application
|
EP2743268A3
(en)
|
2006-06-27 |
2014-10-08 |
Takeda Pharmaceutical Company Limited |
Fused cyclic compounds as GPR40 receptor modulators
|
US20080004281A1
(en)
|
2006-06-28 |
2008-01-03 |
Kalypsys, Inc. |
Methods for the modulation of crp by the selective modulation of ppar delta
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
US8115017B2
(en)
|
2006-06-29 |
2012-02-14 |
Taisho Pharmaceutical Co., Ltd |
C-phenyl 1-thioglucitol compound
|
US20080004325A1
(en)
|
2006-06-29 |
2008-01-03 |
Wyeth |
PTP1B inhibitors
|
EP2035372A1
(en)
|
2006-06-29 |
2009-03-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
|
CN101479249B
(zh)
|
2006-06-29 |
2012-10-10 |
霍夫曼-拉罗奇有限公司 |
苯并咪唑衍生物、其制备方法、它们作为fxr激动剂的用途及含有它们的药物制剂
|
CN101511775A
(zh)
|
2006-06-29 |
2009-08-19 |
詹森药业有限公司 |
丁基和丁炔基苄基胺化合物
|
AU2007265242A1
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Substituted benzyl amine compounds
|
US20080045507A1
(en)
|
2006-06-29 |
2008-02-21 |
Allison Brett D |
Substituted benzamide modulators of the histamine h3 receptor
|
AU2007265240A1
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Substituted aminomethyl benzamide compounds
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
JP4959794B2
(ja)
|
2006-07-05 |
2012-06-27 |
エフ.ホフマン−ラ ロシュ アーゲー |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型(11β−HSD1)の阻害剤としてのアルキルピリダジン誘導体
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
US7888504B2
(en)
|
2006-07-06 |
2011-02-15 |
Bristol-Myers Squibb Company |
Glucokinase activators and methods of using same
|
DE102006031176A1
(de)
|
2006-07-06 |
2008-01-10 |
Bayer Healthcare Ag |
Substituierte Benzoxepino-isoxazole und ihre Verwendung
|
JP5194588B2
(ja)
|
2006-07-06 |
2013-05-08 |
大正製薬株式会社 |
1−チオ−d−グルシトール誘導体を有効成分として含有する糖尿病の予防又は治療剤
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
EP2046753A2
(en)
|
2006-07-06 |
2009-04-15 |
Brystol-Myers Squibb Company |
Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
US7803799B2
(en)
|
2006-07-07 |
2010-09-28 |
National Health Research Institutes |
Selenophene compounds
|
US20080009534A1
(en)
|
2006-07-07 |
2008-01-10 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
US7795291B2
(en)
|
2006-07-07 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method
|
CN101100458A
(zh)
|
2006-07-07 |
2008-01-09 |
上海艾力斯医药科技有限公司 |
具有PPARγ激动剂活性的双苯并咪唑衍生物及其应用
|
FR2903404B1
(fr)
|
2006-07-10 |
2008-08-22 |
Servier Lab |
Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US8134004B2
(en)
|
2006-07-11 |
2012-03-13 |
Pfizer Inc. |
Substituted N-bicyclicalkyl bicycliccarboxyamide compounds
|
US7297710B1
(en)
|
2006-07-12 |
2007-11-20 |
Sanofi-Aventis |
Derivatives of N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide, their preparation and their application in therapeutics
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
US8048908B2
(en)
|
2006-07-13 |
2011-11-01 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
FR2903695B1
(fr)
|
2006-07-13 |
2008-10-24 |
Merck Sante Soc Par Actions Si |
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
EP2050734A1
(en)
|
2006-07-13 |
2009-04-22 |
Kyowa Hakko Kirin Co., Ltd. |
Pentadienamide derivative
|
EP1878721A1
(en)
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
US20100010530A1
(en)
|
2006-07-14 |
2010-01-14 |
Ams Research Corporation |
Balloon Dilation for Implantable Prosthesis
|
CA2657787A1
(en)
|
2006-07-14 |
2008-01-17 |
Merck And Co., Inc. |
2-substituted proline bis-amide orexin receptor antagonists
|
DE602007008434D1
(de)
|
2006-07-14 |
2010-09-23 |
Merck Sharp & Dohme |
Rezeptoren
|
EP2049110B1
(en)
|
2006-07-14 |
2014-08-20 |
Merck Sharp & Dohme Corp. |
Bridged diazepan orexin receptor antagonists
|
TWI332501B
(en)
|
2006-07-14 |
2010-11-01 |
Lg Life Sciences Ltd |
Melanocortin receptor agonists
|
JP5372318B2
(ja)
|
2006-07-14 |
2013-12-18 |
パナソニック株式会社 |
電気化学キャパシタの製造方法
|
JP2009543823A
(ja)
|
2006-07-17 |
2009-12-10 |
ノバルティス アクチエンゲゼルシャフト |
免疫調節剤として使用するための胆汁酸アミドのスルホニルアミノカルボニル誘導体
|
WO2008010061A2
(en)
|
2006-07-17 |
2008-01-24 |
Glenmark Pharmaceuticals S.A. |
3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
|
DE102006033140A1
(de)
|
2006-07-18 |
2008-01-24 |
Merck Patent Gmbh |
Aminoindazolharnstoffderivate
|
EP2051977A2
(en)
|
2006-07-20 |
2009-04-29 |
Amgen Inc. |
SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1
|
KR101149274B1
(ko)
|
2006-07-20 |
2012-05-29 |
노파르티스 아게 |
Cετρ 억제제로서의 아미노-피페리딘 유도체
|
GB2454615A
(en)
|
2006-07-21 |
2009-05-13 |
Lupin Ltd |
Antidiabetic azabicyclo (3.1.0) hexan compounds
|
FR2903984B1
(fr)
|
2006-07-24 |
2008-10-03 |
Genfit Sa |
Derives d'imidazolones substitues, preparation et utilisations
|
EP2049548A1
(en)
|
2006-07-27 |
2009-04-22 |
UCB Pharma, S.A. |
Fused oxazoles & thiazoles as histamine h3- receptor ligands
|
US20100022589A1
(en)
|
2006-07-27 |
2010-01-28 |
Mccoull William |
Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
|
TWI418556B
(zh)
|
2006-07-27 |
2013-12-11 |
Mitsubishi Tanabe Pharma Corp |
吲哚衍生物
|
TWI403516B
(zh)
|
2006-07-27 |
2013-08-01 |
Chugai Pharmaceutical Co Ltd |
To replace spirocyclic alcohol derivatives, and its use as a therapeutic agent for diabetes
|
TWI432446B
(zh)
|
2006-07-27 |
2014-04-01 |
Chugai Pharmaceutical Co Ltd |
稠環螺酮縮醇衍生物、及其做為糖尿病治療藥之使用
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
US20080027014A1
(en)
|
2006-07-28 |
2008-01-31 |
Tanabe Seiyaku Co., Ltd. |
Novel SGLT inhibitors
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
WO2008016730A2
(en)
|
2006-08-02 |
2008-02-07 |
Targeted Molecular Diagnostics, Llc |
Compositions and methods for reducing cellular fat
|
CA2658797A1
(en)
|
2006-08-02 |
2008-02-07 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
|
WO2008016175A1
(fr)
|
2006-08-03 |
2008-02-07 |
Nippon Chemiphar Co., Ltd. |
Agent activant de récepteur activé par les proliférateurs des peroxysomes
|
WO2008016123A1
(fr)
|
2006-08-03 |
2008-02-07 |
Takeda Pharmaceutical Company Limited |
INHIBITEUR DE LA GSK-3β
|
JP5270545B2
(ja)
|
2006-08-03 |
2013-08-21 |
タフツ ユニバーシティー/トラスティーズ オブ タフツ カレッジ |
フラッシングのないナイアシン類似体およびそれらの使用法
|
US7514433B2
(en)
|
2006-08-03 |
2009-04-07 |
Hoffmann-La Roche Inc. |
1H-indole-6-yl-piperazin-1-yl-methanone derivatives
|
EP2058309A4
(en)
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
WO2008019309A1
(en)
|
2006-08-04 |
2008-02-14 |
Metabasis Therapeutics, Inc. |
Novel inhibitors of fructose 1,6-bisphosphatase
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
KR100826108B1
(ko)
|
2006-08-04 |
2008-04-29 |
한국화학연구원 |
퓨란-2-카복실산 유도체 및 그의 제조 방법
|
SG176477A1
(en)
|
2006-08-07 |
2011-12-29 |
Ironwood Pharmaceuticals Inc |
Indole compounds
|
EP1887006A1
(en)
|
2006-08-07 |
2008-02-13 |
Krka |
Polymorphic forms of rosiglitazone base
|
EP2061767B1
(de)
|
2006-08-08 |
2014-12-17 |
Sanofi |
Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
|
WO2008017670A1
(en)
|
2006-08-08 |
2008-02-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
|
JP2010500372A
(ja)
|
2006-08-09 |
2010-01-07 |
スミスクライン ビーチャム コーポレーション |
オピオイド受容体に対するアンタゴニストまたはインバースアゴニストとしての新規化合物
|
EP2054383A2
(en)
|
2006-08-09 |
2009-05-06 |
SmithKline Beecham Corporation |
Novel compounds as antagonists or inverse agonists at opioid receptors
|
WO2008022015A2
(en)
|
2006-08-11 |
2008-02-21 |
Trustees Of Tufts College |
Retro-inverso incretin analogues, and methods of use thereof
|
US7750019B2
(en)
|
2006-08-11 |
2010-07-06 |
Kowa Company, Ltd. |
Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
|
TWI433839B
(zh)
|
2006-08-11 |
2014-04-11 |
Neomed Inst |
新穎的苯并咪唑衍生物290
|
WO2008017852A1
(en)
|
2006-08-11 |
2008-02-14 |
Palatin Technologies, Inc. |
Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators
|
BRPI0715893A2
(pt)
|
2006-08-15 |
2013-09-17 |
Actelion Pharmaceuticals Ltd |
composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
|
CA2656847A1
(en)
|
2006-08-15 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
WO2008021560A2
(en)
|
2006-08-17 |
2008-02-21 |
Amylin Pharmaceuticals, Inc. |
Dpp-iv resistant gip hybrid polypeptides with selectable properties
|
JP2009256208A
(ja)
|
2006-08-17 |
2009-11-05 |
Dainippon Sumitomo Pharma Co Ltd |
フタリド誘導体またはその薬学的に許容される塩
|
WO2008021625A2
(en)
|
2006-08-18 |
2008-02-21 |
N.V. Organon |
Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
|
WO2008024284A2
(en)
|
2006-08-21 |
2008-02-28 |
Merck & Co., Inc. |
Sulfonylated piperazines as cannabinoid-1 receptor modulators
|
ATE530540T1
(de)
|
2006-08-23 |
2011-11-15 |
Pfizer Prod Inc |
Pyrimidonverbindungen als gsk-3-inhibitoren
|
EP2065369A4
(en)
|
2006-08-23 |
2011-12-28 |
Astellas Pharma Inc |
UREA CONNECTION OR SALT THEREOF
|
CN101563349A
(zh)
|
2006-08-23 |
2009-10-21 |
神经能质公司 |
经卤烷基取代的嘧啶酮衍生物
|
AU2007288203B2
(en)
|
2006-08-23 |
2013-01-17 |
Neurogen Corporation |
2-phenoxy pyrimidinone analogues
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
WO2008024497A2
(en)
|
2006-08-25 |
2008-02-28 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
|
ATE458740T1
(de)
|
2006-08-28 |
2010-03-15 |
Actelion Pharmaceuticals Ltd |
1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
|
WO2008029217A2
(en)
|
2006-08-29 |
2008-03-13 |
Orchid Research Laboratories Limited |
Dipeptidyl peptidase iv inhibitors
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
EP1894928A1
(en)
|
2006-08-29 |
2008-03-05 |
PheneX Pharmaceuticals AG |
Heterocyclic fxr binding compounds
|
JP5187901B2
(ja)
|
2006-08-30 |
2013-04-24 |
塩野義製薬株式会社 |
ヒドラジンアミド誘導体
|
JP5207382B2
(ja)
|
2006-08-30 |
2013-06-12 |
塩野義製薬株式会社 |
ウレア誘導体
|
CL2007002499A1
(es)
|
2006-08-30 |
2008-03-14 |
Phenomix Corp |
Sales citrato y tartrato de compuestos derivados de acido pirrolidinilaminoacetilpirrolidinboronico, inhibidores de dpp-iv; metodo de preparacion; forma solida; combinacion farmaceutica, util para el tratamiento de diabetes.
|
CA2660699A1
(en)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Pyridine compounds for treating gpr119 related disorders
|
WO2008027584A2
(en)
|
2006-09-01 |
2008-03-06 |
Vertex Pharmaceuticals Incorporated |
5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
|
US7470697B2
(en)
|
2006-09-01 |
2008-12-30 |
Adenosine Therapeutics, Llc |
Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B adenosine receptors
|
WO2008028188A2
(en)
|
2006-09-01 |
2008-03-06 |
The Ticket Reserve |
Demand aggregation for future items contingent upon threshold demand
|
CA2661404A1
(en)
|
2006-09-05 |
2008-03-13 |
Schering Corporation |
Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
|
JP2008063256A
(ja)
|
2006-09-06 |
2008-03-21 |
Astellas Pharma Inc |
β‐アミノ酸誘導体
|
WO2008031032A2
(en)
|
2006-09-07 |
2008-03-13 |
Transition Therapeutics Inc. |
Compounds for and methods of treating insulin resistance and inflammation
|
US7714008B2
(en)
|
2006-09-07 |
2010-05-11 |
Amgen Inc. |
Heterocyclic GPR40 modulators
|
WO2008028662A1
(en)
|
2006-09-07 |
2008-03-13 |
Santhera Pharmaceuticals (Schweiz) Ag |
N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus
|
CA2662242C
(en)
|
2006-09-07 |
2012-06-12 |
Amgen Inc. |
Benzo-fused compounds for use in treating metabolic disorders
|
JP2010502711A
(ja)
|
2006-09-08 |
2010-01-28 |
ザ スクリプス リサーチ インスティテュート |
脂肪酸アミドヒドロラーゼの置換オキサゾールケトンモジュレーター
|
EP2064199A1
(en)
|
2006-09-08 |
2009-06-03 |
Pfizer Products Inc. |
Diaryl ether derivatives and uses thereof
|
DE102006042143A1
(de)
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
JP2010503654A
(ja)
|
2006-09-12 |
2010-02-04 |
ファイザー・プロダクツ・インク |
ベンゾイミダゾロン誘導体
|
KR100886466B1
(ko)
|
2006-09-12 |
2009-03-04 |
(주)한국씨엔에스팜 |
신규한 스티그마스테롤 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법, 및 이를 포함하는 비만억제 또는 고지혈증 예방 및 치료용 조성물
|
AR062760A1
(es)
|
2006-09-13 |
2008-12-03 |
Takeda Pharmaceutical |
Administracion de inhibidores de dipeptidilpetidasa
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
WO2008033931A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib
|
WO2008033934A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted heteroaryl carboxylic acid derivatives as ptb-1b inhibitors
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
US7781593B2
(en)
|
2006-09-14 |
2010-08-24 |
Hoffmann-La Roche Inc. |
5-phenyl-nicotinamide derivatives
|
US20100016274A1
(en)
|
2006-09-14 |
2010-01-21 |
Koppel Gary A |
Beta-lactam cannabinoid receptor modulators
|
CN101528227A
(zh)
|
2006-09-15 |
2009-09-09 |
先灵公司 |
氮杂环丁酮衍生物及其使用方法
|
MX2009002924A
(es)
|
2006-09-15 |
2009-05-28 |
Schering Corp |
Derivados de azetidinona espirociclica para el tratamiento de trastornos del metabolismo de los lipidos, el dolor, la diabetes y otros trastornos.
|
CN101583612A
(zh)
|
2006-09-15 |
2009-11-18 |
先灵公司 |
治疗脂质代谢障碍的氮杂环丁酮衍生物
|
ES2349066T3
(es)
|
2006-09-15 |
2010-12-22 |
Pfizer Inc. |
Compuestos de piridilmetilbiciclocarboxamida sustituida.
|
MX2009003125A
(es)
|
2006-09-20 |
2009-05-28 |
Lilly Co Eli |
Tiazol pirazolopirimidinas como antagonistas de receptor de crf1.
|
WO2008035356A2
(en)
|
2006-09-20 |
2008-03-27 |
Glenmark Pharmaceuticals Limited |
Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
WO2008036021A1
(en)
|
2006-09-20 |
2008-03-27 |
Astrazeneca Ab |
Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands
|
MX2009003098A
(es)
|
2006-09-20 |
2009-04-01 |
Lilly Co Eli |
Compuestos de tiofen pirazolopirimidina.
|
WO2008036022A1
(en)
|
2006-09-20 |
2008-03-27 |
Astrazeneca Ab |
Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands
|
CA2664095A1
(en)
|
2006-09-21 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
CN101541830A
(zh)
|
2006-09-22 |
2009-09-23 |
诺沃-诺迪斯克有限公司 |
蛋白酶抗性的胰岛素类似物
|
CA2664245A1
(en)
|
2006-09-27 |
2008-04-03 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor modulators
|
EP2097410A4
(en)
|
2006-09-29 |
2009-11-25 |
Green Cross Corp |
HETEROYL-PYRAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS
|
JP2010504957A
(ja)
|
2006-09-29 |
2010-02-18 |
アクテリオン ファーマシューティカルズ リミテッド |
3−アザ−ビシクロ[3.1.0]ヘキサン誘導体
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法
|
KR101077309B1
(ko)
|
2006-09-29 |
2011-10-26 |
에프. 호프만-라 로슈 아게 |
설폰아미드 유도체
|
WO2008039882A1
(en)
|
2006-09-30 |
2008-04-03 |
Sanofi-Aventis U.S. Llc |
A combination of niacin and a prostaglandin d2 receptor antagonist
|
TW200821284A
(en)
|
2006-10-03 |
2008-05-16 |
Merck & Co Inc |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
EP2450350A1
(en)
|
2006-10-04 |
2012-05-09 |
F. Hoffmann-La Roche AG |
3-Pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents
|
WO2008044656A1
(fr)
|
2006-10-06 |
2008-04-17 |
Taisho Pharmaceutical Co., Ltd. |
Dérivé d'imidazolidinone
|
PE20081152A1
(es)
|
2006-10-06 |
2008-08-10 |
Wyeth Corp |
Azaciclilaminas n-sustituidas como antagonistas de histamina-3
|
GB0619860D0
(en)
|
2006-10-06 |
2006-11-15 |
Birkeland Innovasjon As |
Treatment of insulin resistance and disorders associated therewith
|
AR063028A1
(es)
|
2006-10-06 |
2008-12-23 |
Banyu Pharma Co Ltd |
Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
|
WO2008040974A1
(en)
|
2006-10-07 |
2008-04-10 |
Peakdale Molecular Limited |
Indoles for use as dpp-iv inhibitors
|
US8022061B2
(en)
|
2006-10-10 |
2011-09-20 |
Amgen Inc. |
N-aryl pyrazole compounds, compositions, and methods for their use
|
US20110039893A1
(en)
|
2006-10-11 |
2011-02-17 |
Takeda Pharmaceutical Company Limited |
Gsk-3beta inhibitor
|
EP1911747A1
(en)
|
2006-10-11 |
2008-04-16 |
Laboratorios del Dr. Esteve S.A. |
Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
|
US20080139455A1
(en)
|
2006-10-12 |
2008-06-12 |
Forbes Medi-Tech (Research), Inc. |
Compounds and methods of treating metabolic syndrome and inflammation
|
US7705005B2
(en)
|
2006-10-13 |
2010-04-27 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds
|
WO2008044111A1
(en)
|
2006-10-13 |
2008-04-17 |
Pfizer Products Inc. |
Pharmaceutical formulation tablet
|
US20080107725A1
(en)
|
2006-10-13 |
2008-05-08 |
Albano Antonio A |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
|
JPWO2008044762A1
(ja)
|
2006-10-13 |
2010-02-18 |
中外製薬株式会社 |
チオグルコーススピロケタール誘導体、およびその糖尿病治療薬としての使用
|
DE102006048728A1
(de)
|
2006-10-16 |
2008-04-17 |
Merck Patent Gmbh |
3-Amino-imidazo{1,2-a]pyridinderivate
|
CA2849697A1
(en)
|
2006-10-16 |
2008-04-24 |
Alexandros Eleftheriadis |
Systems and methods for signaling and performing temporal level switching in scalable video coding
|
WO2008048648A2
(en)
|
2006-10-17 |
2008-04-24 |
Acadia Pharmaceuticals Inc. |
Cb1-modulating compounds and their use
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
EP2298772A1
(en)
|
2006-10-18 |
2011-03-23 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds
|
CA2666489C
(en)
|
2006-10-19 |
2012-10-02 |
F. Hoffmann-La Roche Ag |
Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
|
US7652133B2
(en)
|
2006-10-19 |
2010-01-26 |
Takeda Pharmaceutical Company Limited |
Indole compound
|
TW200825072A
(en)
|
2006-10-20 |
2008-06-16 |
Arete Therapeutics Inc |
Soluble epoxide hydrolase inhibitors
|
EP2099450A4
(en)
|
2006-10-20 |
2011-01-26 |
Merck Sharp & Dohme |
NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING THESE COMPOUNDS, AND METHODS OF TREATMENT
|
JP2010507587A
(ja)
|
2006-10-20 |
2010-03-11 |
アレテ セラピューティクス, インコーポレイテッド |
可溶性エポキシドヒドロラーゼ阻害剤
|
ES2368460T3
(es)
|
2006-10-23 |
2011-11-17 |
Pfizer Inc. |
Compuestos de fenilmetil biciclocarboxiamida sustituidos.
|
TW200825063A
(en)
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
KR100812538B1
(ko)
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
ATE469122T1
(de)
|
2006-10-24 |
2010-06-15 |
Janssen Pharmaceutica Nv |
Mtp-inhibierende tetrahydronaphthalin-1- carbonsäurederivate
|
JO2653B1
(en)
|
2006-10-24 |
2012-06-17 |
شركة جانسين فارماسوتيكا ان. في |
Tetrahydroflavin 1-carboxylic acid substituted with pyridine or pyrazine inhibit MTB
|
CL2007003061A1
(es)
|
2006-10-26 |
2008-08-01 |
Astrazeneca Ab |
Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
|
US20080103201A1
(en)
|
2006-10-26 |
2008-05-01 |
Wijayabandara Mirihanage Don J |
Novel alpha-Glucosidase inhibitor from Tabernaemontana dichotoma
|
WO2008049711A1
(en)
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
EP2086991A1
(en)
|
2006-10-27 |
2009-08-12 |
Boehringer Ingelheim International GmbH |
CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
|
EP2079467B1
(en)
|
2006-10-31 |
2015-11-18 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
JP2010508358A
(ja)
|
2006-11-01 |
2010-03-18 |
ブリストル−マイヤーズ スクイブ カンパニー |
グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用
|
EP2089389A2
(en)
|
2006-11-01 |
2009-08-19 |
Bristol-Myers Squibb Company |
Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity
|
US7968577B2
(en)
|
2006-11-01 |
2011-06-28 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
CN101535238A
(zh)
|
2006-11-01 |
2009-09-16 |
普罗诺瓦生物医药挪威公司 |
作为过氧化物酶体增生物激活受体(PPAR)的活化剂或调节剂的α-取代的ω-3脂质
|
WO2008057856A2
(en)
|
2006-11-01 |
2008-05-15 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
|
ATE550337T1
(de)
|
2006-11-01 |
2012-04-15 |
Bristol Myers Squibb Co |
Modulatoren der glucocorticoidrezeptor-, ap-1- und/oder nf-kappa-b-aktivität und deren verwendung
|
US8263587B2
(en)
|
2006-11-02 |
2012-09-11 |
Piramal Healthcare Limited |
Benzoxazepine compounds, their preparation and use
|
WO2008057336A2
(en)
|
2006-11-02 |
2008-05-15 |
Merck & Co., Inc. |
Heterocyclyl-substituted anti-hypercholesterolemic compounds
|
EP1918281A1
(en)
|
2006-11-02 |
2008-05-07 |
Laboratorios del Dr. Esteve S.A. |
Phenylamino-substituted piperidine compounds, their preparation and use as medicaments
|
CN101535249A
(zh)
|
2006-11-02 |
2009-09-16 |
塞诺菲-安万特德国有限公司 |
具有改善的药理性质的新的哌嗪-1-磺酸取代的二苯基氮杂环丁酮
|
EP2086965B1
(en)
|
2006-11-02 |
2010-02-10 |
Vertex Pharmaceuticals, Inc. |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
TW200827346A
(en)
|
2006-11-03 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
RU2009117203A
(ru)
|
2006-11-03 |
2010-12-10 |
Гленмарк Фармасеутикалс С.А. (Ch) |
Новые лиганды каннабиноидных рецепторов, фармацевтические композиции, содержащие данные лиганды, и способы их получения
|
EP1918285A1
(en)
|
2006-11-03 |
2008-05-07 |
Merck Sante |
Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors
|
WO2008056377A2
(en)
|
2006-11-06 |
2008-05-15 |
Cadila Healthcare Limited |
Polymorphic forms of rimonabant
|
EP2079753A1
(en)
|
2006-11-06 |
2009-07-22 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
|
EP1921080B1
(en)
|
2006-11-07 |
2009-08-05 |
Sanofi-Aventis |
Subsitituted 8-piperidinyl-2-pyridinyl-pyrimido(1,2-a)pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido(1,2-a)pyrimidin-6-one derivatives
|
JP2010043001A
(ja)
|
2006-11-09 |
2010-02-25 |
Sanwa Kagaku Kenkyusho Co Ltd |
Glp−1誘導体とその用途
|
NZ598778A
(en)
|
2006-11-09 |
2013-09-27 |
Boehringer Ingelheim Int |
Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
|
EP1921072A1
(en)
|
2006-11-10 |
2008-05-14 |
Laboratorios del Dr. Esteve S.A. |
1,2,3-Triazole derivatives as cannabinoid-receptor modulators
|
GB0622569D0
(en)
|
2006-11-11 |
2006-12-20 |
7Tm Pharma As |
Cannabinoid receptor modulators
|
KR20090064478A
(ko)
|
2006-11-13 |
2009-06-18 |
화이자 프로덕츠 인크. |
디아릴, 디피리디닐 및 아릴-피리디닐 유도체, 및 이들의 용도
|
DE102006053636B4
(de)
|
2006-11-14 |
2008-09-18 |
Sanofi-Aventis Deutschland Gmbh |
Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate und deren Verwendung
|
ATE493992T1
(de)
|
2006-11-14 |
2011-01-15 |
Sanofi Aventis Deutschland |
Neue 1,4-benzothiepin-1,1-dioxidderivate mit verbesserten eigenschaften, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE102006053637B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
CA2669221A1
(en)
|
2006-11-15 |
2008-05-22 |
Novartis Ag |
Heterocyclic derivatives as cetp inhibitors
|
KR20090078352A
(ko)
|
2006-11-15 |
2009-07-17 |
노파르티스 아게 |
유기 화합물
|
EP2111865B1
(en)
|
2006-11-17 |
2019-10-02 |
National University Corporation Kagawa University |
Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
|
CA2669915C
(en)
|
2006-11-17 |
2012-02-07 |
Pfizer Inc. |
Substituted bicyclocarboxyamide compounds
|
CN101595109B
(zh)
|
2006-11-20 |
2012-09-05 |
百时美施贵宝公司 |
作为二肽基肽酶ⅳ抑制剂的7,8-二氢-1,6-二氮杂萘-5(6h)-酮和相关二环化合物及方法
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
AU2007334519A1
(en)
|
2006-12-14 |
2008-06-26 |
Merck Sharp & Dohme Corp. |
Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
|